ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001060.1|Dynemicin_1 # 1 # 147 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.714	BGC0001060.1|Dynemicin_1 	1	147	-	Loose	200	31.5722	vanH gene in vanB cluster	43.24	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAAGATCGGAATCATCGGGTCGGGGCACATCGGCGGCACCCTCACCCGTCGACTGCGCACGCTGGGCCACGACGTCACGGTGGCCAACTCGCGGGGGCCGCAGAGCCTGACCGACCTGGCCACGGAGACCGGCGCGACGGCCGGC	MKIGIIGSGHIGGTLTRRLRTLGHDVTVANSRGPQSLTDLATETGATAG	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	15.17	gnl|BL_ORD_ID|4673|hsp_num:0	626			441	552	vancomycin
BGC0001060.1|Dynemicin_5 # 6575 # 6925 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.746	BGC0001060.1|Dynemicin_5 	6575	6925	-	Loose	800	24.2534	Staphylococcus aureus LmrS	62.5	3004572	protein homolog model	n/a	n/a	macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGCGCTGTGCGGGGTGCGCGAGCGCTGCGCGGCGCTCGCCGGTGTCGACCCCGAGGCGCTCGCCCAGACCCTTGTCACCCGCTATCCGCCGGACTCCGTCATCGGCTGGCACCGCGACGCGCCCGCCTTCGGGCCGACAGTCGTCGGCCTCTCGCTGGGCTCCGCGTGCCTGTTGCGCTTCCAGCGCTCCACCGGGGAGAACCGCCGGGTGTACGAGCTGGAGCTGTCGCCCCGCTCCGGGTACGTGCTCACCGGGGCGGCCCGGTCGGCGTGGCAGCACAGCATTCCGCCAGTCCCGGCGCTGCGCTACTCGCTGACCTTCCGCACGCTCCGGTCCCCGCGCTCCTGA	MALCGVRERCAALAGVDPEALAQTLVTRYPPDSVIGWHRDAPAFGPTVVGLSLGSACLLRFQRSTGENRRVYELELSPRSGYVLTGAARSAWQHSIPPVPALRYSLTFRTLRSPRS	MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF	24.17	gnl|BL_ORD_ID|2869|hsp_num:0	3276			444	492	erythromycin; streptomycin; kanamycin A; linezolid; trimethoprim; chloramphenicol; florfenicol
BGC0001060.1|Dynemicin_6 # 7206 # 7679 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.741	BGC0001060.1|Dynemicin_6 	7206	7679	-	Loose	300	23.483	AAC(3)-Ic	43.75	3002531	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCAGATGCAGCGGCTCATTCGACGAATCGGGATCGCGGCGGCCGTGGCGGCCGTCCTCGTCGGGGTGGCGGGGACCGGCGCGCAGGCGGCGGCGGTCAACCCGTACACCCCGGAGGCGCTCTGCGGCCCGGGCTTCGTCGCCGTCGACCAGGACCCGATCCACGACACCGCCACCGGCGCGCGGCTCGGCACCGTCCACCTGCTGCGCAACCCCCTCACCGGGTACGGCTGCACGGTCACCCTCAAGTCCGCGTACGTCGGGACGCTCACCGGGACCCGCGTCTACCTGGATCCGGAATGGACCGCCTTCGGCGTCGACGACGGCAGCCGGCGCTACGCGGCCGGCCCGGTCCACCGCTACATCGGCGCGGGTTGTGCCATCTGGGGCGGGTCGATGACCGACCCCGCCGGCGCCGTCCACCAGCACGACCGCGCGAACCCGGCCATCGGCGGGGCGGTCACCTGCTTCTGA	MQMQRLIRRIGIAAAVAAVLVGVAGTGAQAAAVNPYTPEALCGPGFVAVDQDPIHDTATGARLGTVHLLRNPLTGYGCTVTLKSAYVGTLTGTRVYLDPEWTAFGVDDGSRRYAAGPVHRYIGAGCAIWGGSMTDPAGAVHQHDRANPAIGGAVTCF	MISTQTKITRLNSQDVGVMRAMLGMFGEAFEDAENYCRAQPSDSYLQDLLCGSGFIAIAALQGQEVIGGLAAYVLPKFEQQRKEIYIYDLGVQGAYRRRGIATALINELQRIAHDIGAYVIFVQADYGDDPAVALYTKLGIREDVMHFDIEPQPAA	100.64	gnl|BL_ORD_ID|1035|hsp_num:0	1131			126	174	astromicin; sisomicin; gentamicin
BGC0001060.1|Dynemicin_7 # 7960 # 8406 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=8bp;gc_cont=0.727	BGC0001060.1|Dynemicin_7 	7960	8406	+	Loose	575	28.1054	ORN-3	32.39	3006959	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	ORN beta-lactamase	ATGCAGCCGTTCAATCCGTGGATCTGGCGGGACCCGTCCGCCCTCGCCGGCGGCTACGAGCAGACCCGCCCGGACGACGTGCCGCGGCAGCGGTCGGACGGTGGCGCCGACGACGGCCCCGACGCGCCCGGCCCGGGCACTCCGATCGACCTCACCGGCTACCTGGTGGAGGCGACCGACGGCCGGATCGGCGCGATCGACCAGGCGAGCGACGACGCCGGCGCCGGCTACCTGGTGGTGGACACCGGGCCGTGGATCTTCGGTCGGAAGGTGCTGCTGCCGGTCGGCACGGTGGCCCGGGTCGACCACCTGGAGCGCGTCGTGCACGTGGACCGGACGCGGGAGCAGGTCAAGGAGTCACCGGCGTTCGACCCGGACGACTTCGGCCGCACCGAATACCGCGAGCAGGTTGGCAACTACTACACCGAGAGCTACCGGCGGGGCTGA	MQPFNPWIWRDPSALAGGYEQTRPDDVPRQRSDGGADDGPDAPGPGTPIDLTGYLVEATDGRIGAIDQASDDAGAGYLVVDTGPWIFGRKVLLPVGTVARVDHLERVVHVDRTREQVKESPAFDPDDFGRTEYREQVGNYYTESYRRG	MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYCAGERFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCAAAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPEAMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRGIIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP	50.86	gnl|BL_ORD_ID|3727|hsp_num:0	4797			108	318	
BGC0001060.1|Dynemicin_8 # 8750 # 9808 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.701	BGC0001060.1|Dynemicin_8 	8750	9808	+	Loose	500	27.335	OXA-85	40.0	3001780	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTCCGCAGCACGGATGCTCACCGGTGACCGCCCGACCGGGCGGCTGCACCTCGGCCACTACGTCGGCAGCATCGCCAACCGGGTGAAGCTGCACCAGCACTACGAGAGCTTCTTCATCATCGCCGACCTGCACATGCTCACCACGCGCAACAGTCGCGAGGACATCGAGCAGGTCTCCCACAACGCCCGCGAGATGGTCACCGACATCCTCGCCGCCGGTGTCGAACCGGACCGGGCCACCTTCTACCTCCAGTCGGCGATCCCCGAGGTCGGCGACCTGAACACCCTGTTCCAGAACCTGGTCACCGTGCCCCGGCTGGAACGGGTCCCGTCGCTCAAGGAGATGAGCCGGGACGCCGGCAAGGAGGAGATGCCGTACGGGCTGCTCGGCTATCCCGTCCTCCAGGCCGCCGACATCCTCTGCGTGAAGGGGCAGGTCGTCCCGGTGGGGAAGGACAACGCCGCGCACGTCGAGGTGACCCGGGAGATCGCCCGGCGCTTCAACCACCTCTACGGCGAGGTCTTCCCCGTGCCGGAAATGATCATGTCGGAGACGCCCACCCTGGTCGGCACCGACGGCGCGGGGAAGATGAGCAAGAGCAAGGGAAACGCCATCGCGCTCTCCGACGACCCGGCCACCGTGCGGCGCAAGGTGCTGGGGATGTACACCGACCCGAACCGGGTCCGCGCCGACGTGCCGGGCACGGTCGAGGGGAACCCGGTCTTCGCGTACCTCGACGTGTTCCACACCGACCGGGCGACGGTCGAGGAGCTGAAGGCGCGCTACCGGGCCGGCCGGGTCGGCGACGTCGAGGTCAAGGAGGAACTGGTGGGCGCGCTCAACCGGTTCCTCGACCCGGTCCGCGAGCGGCGGGCCCGGTTCGAGGGGCAGCGCGGCCTGGTCGACGAGCTGATCGTCGAGGGCACCGAGCGGACCCGGGCGCAGGTGCGCCGCACCCTTGTCGAGGTGCGCCGGGCCATGGGCCTGACCAGCGCGTACACCCAGGTGCGGCGGCGGGCCGAGCGCTACCGCAAGGCCGTCGGCACGCCGGCCTGA	MSAARMLTGDRPTGRLHLGHYVGSIANRVKLHQHYESFFIIADLHMLTTRNSREDIEQVSHNAREMVTDILAAGVEPDRATFYLQSAIPEVGDLNTLFQNLVTVPRLERVPSLKEMSRDAGKEEMPYGLLGYPVLQAADILCVKGQVVPVGKDNAAHVEVTREIARRFNHLYGEVFPVPEMIMSETPTLVGTDGAGKMSKSKGNAIALSDDPATVRRKVLGMYTDPNRVRADVPGTVEGNPVFAYLDVFHTDRATVEELKARYRAGRVGDVEVKEELVGALNRFLDPVRERRARFEGQRGLVDELIVEGTERTRAQVRRTLVEVRRAMGLTSAYTQVRRRAERYRKAVGTPA	MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEIVREYFKNINVIK	138.58	gnl|BL_ORD_ID|260|hsp_num:0	289			291	381	cloxacillin; oxacillin; cefalotin
BGC0001060.1|Dynemicin_9 # 10091 # 11809 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.749	BGC0001060.1|Dynemicin_9 	10091	11809	+	Loose	910	27.335	mtrE	36.17	3000812	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGATCTGGAGAAACTGCTGACCGACCGGCTGGCGCCGGCGTTCGCCACGGTGGCCGGCGGGCCGGTGGACCCGGTCGTGCGGCGCTCCCAGCGCGCGGACTTCCAGTCGGACGCGGCGCTGGCGCTGGCGCGGCGGCTCGGCCGGCCGCCGCGCGCCATCGCCACCGAGGTGCTGGAGCGCGCGGAACTGGCCGACCTGTGCAGCGCCACGGAGGTCTCCGGGCCGGGTTTCCTCAACCTGACCGTGGCCGACGACGCCCTGGCCGGGCTGGTCTCCGCGCTGGCCGCCGACCCGCGGCTCGGGGTGCCGGAGGCCGCCGCGCCGGAGACCGTGGTGGTCGACTACTCCGCGCCGAACGTGGCGAAGGAGATGCACGTCGGGCACCTGCGCTCGACGGTGATCGGCGACGCGGCGGCCCGGCTGCTGGAGTGGCTGGGGCACCGGGTGCTGCGCGCCAACCACCTGGGCGACTGGGGCACGCCCTTCGGCATGCTGATCGAGCACCTGGTCGACCTGGGCGAGGCCGAGGCGGCGCAGGAGCTGTCGATGGGCGACCTGGACTCGTTCTACAAGGCGGCCCGGGCCAAGTTCGACGCCGACGAGGCGTTCCGCGAGCGGGCCCGGCAGCGGGTGGTGGCGTTGCAGGGCGGCGACGCGACCACCCTGCGCCTCTGGCGGCTGCTCGTGGAGCAGTCCGAGCGCTACTTCCTGACCGTCTACGACCTGCTCGACGTGACCCTCACCGAGCGGGACTTCCACGGCGAGAGCAGCTACAACGACCTGCTCGGCCCGGTCGTCGAGGACCTGGACCGGCTCGGGCTGCTGCGGTCCAGCGACGGCGCGGCGTGCGTGTTCCCGCCCGGCTCGGTGGGCCGGGACGGGGAGCCGCTGCCGCTGATCGTGCGCAAGTCCGACGGCGGGTACGGCTACCCGGCGACCGACCTCGCCGCGATCCGGCACCGGACCGGCACGCTGGGCGCGACCCGGCTGCTCTACGTGGTCGGGCTGCCGCAGCGGCGGCACTTCGAGATGGTCTACGCCGCCGCCGCGCAGGCCGGTTGGTTGGCCCCGCCGGCCCGGGCCGAGCACGTCGGGTTCGGCTCGATCCTCGGCCCCGACGGGCGGATGCTGCGCAGCCGGGCCAGCGGGTCGGTCAAGTTGGTCGGGCTGCTGGAGGAGGCGGTGGCCCGGGCCACCGCGCTGGCCCGGGAGCGGAACCCGGAGCTGGGCGAGGCCGAGGCGGCCGAGGTGGGCCGCGCGGTCGGCATCGGCGCGGTCAAGTACGCCGACCTCTCCAGCGACCGGCACAAGGACTACGTGCTCGACTGGGAGCGGATGCTGTCGCTGGACGGCAACAGCGCGCCCTACCTCCAGTACGCCCACTCCCGGATCCGGTCGATCTTCCGGCGGGCCGGGGTTGCGGCCCGGCCCGAGGCACCGGTCTCGCTGGTGGATCCGGCCGAGCGGGCGCTCGCCTTCGAGCTGGTCGGCTTCGGGGCGGTGGTCGGCGCGGTGGCGGAGAACCTGGAGTTCCACCACCTGACCGCTTGCCTGTCCCGGCTCGCCGCCGCGTTCAGCGCGTTCTACGAGCGGTGCCCGGTGCTGCGGGCCGACGAGCCGGTCCGGGAGAGCCGGCTGGTGCTCTGCGACCTGACCGCGCGGGTGCTCCGGCAGGGCCTCCACCTGCTCGGCATCCGCACCCCGGAGCGGCTGTGA	MDLEKLLTDRLAPAFATVAGGPVDPVVRRSQRADFQSDAALALARRLGRPPRAIATEVLERAELADLCSATEVSGPGFLNLTVADDALAGLVSALAADPRLGVPEAAAPETVVVDYSAPNVAKEMHVGHLRSTVIGDAAARLLEWLGHRVLRANHLGDWGTPFGMLIEHLVDLGEAEAAQELSMGDLDSFYKAARAKFDADEAFRERARQRVVALQGGDATTLRLWRLLVEQSERYFLTVYDLLDVTLTERDFHGESSYNDLLGPVVEDLDRLGLLRSSDGAACVFPPGSVGRDGEPLPLIVRKSDGGYGYPATDLAAIRHRTGTLGATRLLYVVGLPQRRHFEMVYAAAAQAGWLAPPARAEHVGFGSILGPDGRMLRSRASGSVKLVGLLEEAVARATALARERNPELGEAEAAEVGRAVGIGAVKYADLSSDRHKDYVLDWERMLSLDGNSAPYLQYAHSRIRSIFRRAGVAARPEAPVSLVDPAERALAFELVGFGAVVGAVAENLEFHHLTACLSRLAAAFSAFYERCPVLRADEPVRESRLVLCDLTARVLRQGLHLLGIRTPERL	MNTTLKTTLTSVAAAFALSACTMIPQYEQPKVEVAETFQNDTSVSSIRAVDLGWHDYFADPRLQKLIDIALERNTSLRTAVLNSEIYRKQYMIERNNLLPTLAANANGSRQGSLSGGNVSSSYNVGLGAASYELDLFGRVRSSSEAALQGYFASVANRDAAHLSLIATVAKAYFNERYAEEAMSLAQRVLKTREETYNAVRIAVQGRRDFRRRPAPAEALIESAKADYAHAARSREQARNALATLINRPIPEDLPAGLPLDKQFFVEKLPAGLSSEVLLDRPDIRAAEHALKQANANIGAARAAFFPSIRLTGSVGTGSVELGGLFKSGTGVWAFAPSITLPIFTWGTNKANLDVAKLRQQAQIVAYESAVQSAFQDVANALAAREQLDKAYDALSKQSRASKEALRLVGLRYKHGVSGALDLLDAERSSYSAEGAALSAQLTRAENLADLYKALGGGLKRDTQTGK	122.48	gnl|BL_ORD_ID|409|hsp_num:0	453			360	630	erythromycin; penicillin; azithromycin
BGC0001060.1|Dynemicin_10 # 11868 # 12233 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.760	BGC0001060.1|Dynemicin_10 	11868	12233	-	Loose	100	29.261	FosA8	23.68	3007371	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGAGCGTGCATCCCCGCGTCGTCGCCGACGACTTCCCGGCCACCCTCCGCTTCTACGCCGACCTGCTCGGCGAGCCGGAGAAGGTCGTCGCCGAGTTCGAGTACGCCAGCTTCGACGCCGGCGGCGAGACCGTGCTCGCCGTGCTGGGTCGCCGGGCGGCCGAGGCGGTGCTGCCGGTGGGCCGGGGGGACGGCGGCGTGCTCGTGGTGGTCCCGGTGCCGGACGTCGACGCCACAGTCGCCGCCCTCCCCGCCGGCACGGTCGTCGCCGCGCCGGCCGACCGCCCCGGCTGGGGCGTCCGCTCGGCCTACCTGCGCGATCCGGAGGGCAACCTGGTCGAGGTGCAGACCTGGCTGCCGCGCTGA	MSVHPRVVADDFPATLRFYADLLGEPEKVVAEFEYASFDAGGETVLAVLGRRAAEAVLPVGRGDGGVLVVVPVPDVDATVAALPAGTVVAAPADRPGWGVRSAYLRDPEGNLVEVQTWLPR	MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA	85.82	gnl|BL_ORD_ID|4906|hsp_num:0	5899			18	345	fosfomycin
BGC0001060.1|Dynemicin_11 # 12244 # 13353 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGCGG;rbs_spacer=4bp;gc_cont=0.790	BGC0001060.1|Dynemicin_11 	12244	13353	-	Loose	500	26.9498	mefJ	43.75	3007049	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCGTGACGTCCTGCCCGACCTGCTGCGCTGGTGGCGTGCCGGCGTGCCGGTCGGCATGGCCACGGTGGCCCGCACCTGGCAGAGCGCCCCGCGCCGGCCCGGTGCCACGCTGCTGGTCGGGCCGGACGGCAGCGCGGTCGGCAGTGTCTCCGGCGGCTGCGTGGAGGCGGCGGTCTACGAGCTGTGCCGGGAGGTCGTCGCCGACGCCACGCCGCGGTCGGTCCGCTTCGGGGTGAGCGACGACGACGCACTGGCCGCCGGCCTCACCTGCGGCGGGACCGTCGAGCTGTACGTGGAGCGGGTCGACCGGGAGAGCTTCCCGCAGCTCGACCGGGTCGCCGCCGAGGTCGCCGCTGGCCGGCCCGTGGCGGTCGCGACCTGTGTGGACGGCCCGCCGGGCCGGCGGGGCCGGCGGATCGTGCTGGACGCCGAGGGGCGGCACGGCAGCCTGGGCGAGCCGGCCGTGGACGCGGCGGTCGCCGCCGAGGCGCGGGCGCTGCTGCGCGCGGGCCGCTCCGGCGTGGTCCGCCCCCGGCCGGTCGGGGAGGAGCTGTCCGTGCTGGTGGTGGCCGCTCCGGCGCCGGCCCGGATGCTGGTCTTCGGGGCCGTCGACTTCGCAGCCGCGGTGGCCCAGGCGGGCCGGTTCCTCGGCTACCGGGTGACGGTCTGCGACGCCCGGCCGGTCTTCGCCACCCCGCGGCGGTTCCCCGGGGCGCACGAGGTGGTGGTCGACTGGCCGCACCGCTACCTGGCCGCCGAGGCCGCGGCCGGCCGGGTCGACGCCCGGACCGTGGTCTGCGTACTCACCCACGACGCCCGCTTCGACGTGCCGGTCCTGCGCCACGCTCTCGACCTGCCGCTGGCGTACGTCGGGGCGATGGGCTCCCGGCGCACCGCCGAGGACCGGCGACGCCGCCTGCGCGAGGCCGGCGTGACCGAGGCGGCACTGGCCCGGCTGCGCGCCCCGATCGGCCTGGACCTGGGCGGGCAGACGCCGGAGGAGACCGCCGTCAGCATCGCCGCCGAGATCGTGGCGGTGACGCGCGGCGGTGGCGGCGTCCCGCTGTCCCGCCTGGCGGGCCGCATCCACGCGGACGCGCCCCGCTAG	MRDVLPDLLRWWRAGVPVGMATVARTWQSAPRRPGATLLVGPDGSAVGSVSGGCVEAAVYELCREVVADATPRSVRFGVSDDDALAAGLTCGGTVELYVERVDRESFPQLDRVAAEVAAGRPVAVATCVDGPPGRRGRRIVLDAEGRHGSLGEPAVDAAVAAEARALLRAGRSGVVRPRPVGEELSVLVVAAPAPARMLVFGAVDFAAAVAQAGRFLGYRVTVCDARPVFATPRRFPGAHEVVVDWPHRYLAAEAAAGRVDARTVVCVLTHDARFDVPVLRHALDLPLAYVGAMGSRRTAEDRRRRLREAGVTEAALARLRAPIGLDLGGQTPEETAVSIAAEIVAVTRGGGGVPLSRLAGRIHADAPR	MENNKWKQKFFAIYTGQFFSLLSSAAVQFGIIWWLTDKTGGSPLLLTLAGLAGFLPQALVGPFAGTITDRYSRKFLMISADMTVALGSLILFLILHFYEANIIFVILILALRSLATAFHMPAMQASIPLLAPEEALTKVAGWGQMVASVSNIVGPAVGMSILSVSSIKWVLLLDILGAVVASGILLFINIPKIQKTESVELTSFFVEMKEGYNALVNHPILLKLTILMTIVAVLYIPLGTYFPLMTRNHFGKGVVEAGTVEIAFAIGLIVGGSLLGIIGDKFEKVKTMAIGMLLMGLALFFSGLLSPSLFFIFIILSGLVGFSGPLFSAPFYAYIQTEIEPQLLGRIFSFVTSLSLLATPIGYALSGLLIEFTSVSILFSIIGVLVILSGLITLKVK	92.95	gnl|BL_ORD_ID|4754|hsp_num:0	5748			1056	1152	
BGC0001060.1|Dynemicin_13 # 13934 # 15853 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=14bp;gc_cont=0.778	BGC0001060.1|Dynemicin_13 	13934	15853	-	Loose	1700	32.7278	LpeB	29.03	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCTACGCTGCGGGGGAGACAGGCGACTGGAAGGATCACCGGTCCCGTGAAACGTCAGCTGTCGGTCACCGTGCTCGGCACGGTCCAGGTCCACGACGGCACCGCCCCGGTGGATCTCGGCCCGTCGAAGCAGCGCGCCCTGCTCGCCCTGCTGGCCCTCCAGGTGGGCGAGAACATCCCCGTCGGCGCGCTCGCCCTGGCGCTGTGGGGCGACAACCCCCCGCCCAGCGGCAGCCACCTCCTGCACACCTACGTGGCGCGGCTGCGGCGGGCGCTGGAACCCGGCTCGCCCCGGCACGCCCGCACCAACGTCATCGCGTCGTCGCCCCGGGCGTACCGGTTGCAGCTCTACGCCGACCAGGTCGACCTGACCCGGTTCCGCCGGCTCGCCGAGGCCGCGCGGGAGCTGATCCGCCGCGACCGGCGGTCCGCCGCCTTCGAGCTGCTGGACGCGGCCGTCGCCATGTGGACCGACCCCGACCTCACCGACCTGCGGGCCCTGCTGCCCGGGGAGGAGGCGGTCGCGGCGCTGCGCCGCGAATGGGTCACCGCCTGCCTCGACCTGGTCACCCTCGGCCTCGAACTCGACCGGCCCGCCGCGGTGCTGGCCACCGCGGAACACCTCGCCGCCGCCGAGCCGCTGCACGAGGCGGTGCAGGCGCGGCACCTCACCGTGCTGGCGCGCACGGGCCGGCGGGCGGCCGCCCTGGACCGGTTCGCCGGGATCCGCGCCCGGCTCGCCGCCGAGCTGGGCATCGAACCGGGCCCCGAGCTGACCGCGGCCCACCGCGAGCTGCGGGACGGCCCGGCGGCCGCCCGGCCGGCGGTCCCGCCGCCCGGCTGCGTGGCGAGCCGGCCCCGGCCGCCCTGGCGCGGCACCCGGCCCGGCGCGACCGAGCTGATCGGCCGGGAGACCGACCTGGCCCGGGTGACCGGGCTGCTCACCGACCACCGGGTGGTCACCGTGGCCGGGCCGGCCGGCTGCGGCAAGTCGGCGCTGGCCCTGGCCGCCGCCCGCCGGGTCCACCCCGGGTACGCCGACGGCGTCCTGTCCGTCGACCTCGCCGCGGCCCGCACGCCGGACGACGTCACCCGGGAGATCCGCCGGCTGCTCCGCCTGCCCGAGCGGGGCGGCCTGCCCCGGCTGCTGGCCGACCGCCACCTGCTGCTCGTGCTGGACAACGTGGACCACCTCACCGACAGCTGCGCCGGCCTGGTCGACGACGTCGTGCAGGTGGGCCGCCGGGTGTCGGCGCTGGTCACCTCGCGGGAGCCGCTGGGCCTGGCGTACGAGTCGGTGTGGCGGCTGCCGCCGCTGCCCGCGCTCACCACCGGCCCGGACGGCGTCCGGGGGATGCCGGCCGTCCAGCTCTTCGCCCGCCGGGCGGCCCAGGCGCGTCCCGGCTTCGAGGTGGGCGCGAAGGAGATCGGCACGGTGGCGGTGATCTGCGGGCTGCTCGACCGGCTGCCCCTCGCCGTCGAACTGGCCGCCGACCGGATGGCCGACGAGAGCCTCGACGAGCTGCTGCGCCGGCTCGACGACCCGCTGACCGCGCTGCGCCGGCCCGACCGGCGGGGGCGGCCGGCCCACCAGACCTCGCTCTCCGCCGCCCTCCAGCGCAGTCTCGACTGCCTCACCCCGGCCGAGCGCTGGTGCTTCGTACGGCTCGGCGCGCTGCCCCGGCTCTTCGGCCTCGACGAGGTGGACCGGGTCTGCGGCGCCGCGCCCTGGTGGCGGCTGCGGACCAGCGTGGTCCTCGACGGCCTGGTGGCGAAGTCCCTGGTGACGGTCCGCCACCACGCCGGCCGCCCCACGTACGCGATGCTGCGCACCGTGCACCAGTTCGCCGCCCGGCTGCTCGCCGGCGAGCTGGGCCAGTACGGCAGCGCACCGGCCCTGTCCGCGCGGGTGGGCTGA	MPTLRGRQATGRITGPVKRQLSVTVLGTVQVHDGTAPVDLGPSKQRALLALLALQVGENIPVGALALALWGDNPPPSGSHLLHTYVARLRRALEPGSPRHARTNVIASSPRAYRLQLYADQVDLTRFRRLAEAARELIRRDRRSAAFELLDAAVAMWTDPDLTDLRALLPGEEAVAALRREWVTACLDLVTLGLELDRPAAVLATAEHLAAAEPLHEAVQARHLTVLARTGRRAAALDRFAGIRARLAAELGIEPGPELTAAHRELRDGPAAARPAVPPPGCVASRPRPPWRGTRPGATELIGRETDLARVTGLLTDHRVVTVAGPAGCGKSALALAAARRVHPGYADGVLSVDLAAARTPDDVTREIRRLLRLPERGGLPRLLADRHLLLVLDNVDHLTDSCAGLVDDVVQVGRRVSALVTSREPLGLAYESVWRLPPLPALTTGPDGVRGMPAVQLFARRAAQARPGFEVGAKEIGTVAVICGLLDRLPLAVELAADRMADESLDELLRRLDDPLTALRRPDRRGRPAHQTSLSAALQRSLDCLTPAERWCFVRLGALPRLFGLDEVDRVCGAAPWWRLRTSVVLDGLVAKSLVTVRHHAGRPTYAMLRTVHQFAARLLAGELGQYGSAPALSARVG	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	63.02	gnl|BL_ORD_ID|2387|hsp_num:0	2759			816	990	erythromycin; spiramycin; azithromycin
BGC0001060.1|Dynemicin_14 # 15908 # 16993 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.745	BGC0001060.1|Dynemicin_14 	15908	16993	+	Loose	545	26.5646	OXA-443	24.29	3003599	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCGCTTCAAGAATGCTGCATACCGCTCGTGTCAGGCTGCTTCATGTTTGCCACCCCCGGTGTGGAACTTGCGCCGGGCGCAGACCAAGGGGGAGCACATGACATCGACGCTCACGCGGGACGGGGTGCACCGACCCGGCGGCTGGCGGAGCCGGTTGGCGCTGAGTCCGGACCTGGTGGACTTCGCCAACCGCGGCTTCCGGACCGACCGCCCTGAGACGAGGTACGTCCTGGAACGCGCCGCCACCGCCTTCCTCGACGGCTACAACCGCGGCCTGGACACGCCGTACGGGCAGCCGACCACACTGGACGGCATCCCGGCTGACCTGCGCGGATTCGCCGCCGAGGGGTCGGCCATGTCGGCCGTGCTGCTGGACCGGCTGTCGCCCCGGCGGCACGGCCGCTTCGCCGCCCAGTTGCGCGGGCACCCGCGCCACGACTACCTGCTGCACGTCGGCGCGGGCTGGGCGCTGGCCAAGCTGGACGCCGTCTCGGTCGGTGCGCTGGGGCGGCTCGGCCGCCTCGGATCGGAGAATGGCCTGCTCCGCTGGCTGGCGTACGACGGCTATGGCTTTTTCAAGGTCTTTTTCGTCAAGGATCCGACCCTCGCGGGCTGGCGCCGGCACCGGAAGCCCTGCGACCCGACCTGCGCCATCCGCTACCAGGGGCTGGGTCGCTGCCTCTGGTTCCGCGACTGCGGCGACCCGGCCGCCCTGGCCGAGCGGATCAGCGGCCTGCCGGCCTCGCACCGTGGTGACGTGTGGAGCGGCGTCGGCCTCGCCGCCACGTACGCCAACGGGGTTTCCCCGGACGACCACGCCCTGCTGCTGCGGCTCGCCGGCAACCACCGGCCCGCCCTCGCCCAGGGCGCCGCGTTCGCGGCGGAGGCCCGCCGGGCGGACGGCACCGCGGGCCCGGCGGTCGACGCCGCCACCCGGACCCTGACCGGGGTGTCCGCCGACACCGCCGCCGAGTGGACCTGGCAGGCCCGGCACGGCCTGGACCGGGCCGGCGCCACCCCGGCCGACTACGGCGAGTGGCGCGCCCGCGTGCAGCGGCTCGCCGCCCGGCACGTCGCCGGCTGA	MRFKNAAYRSCQAASCLPPPVWNLRRAQTKGEHMTSTLTRDGVHRPGGWRSRLALSPDLVDFANRGFRTDRPETRYVLERAATAFLDGYNRGLDTPYGQPTTLDGIPADLRGFAAEGSAMSAVLLDRLSPRRHGRFAAQLRGHPRHDYLLHVGAGWALAKLDAVSVGALGRLGRLGSENGLLRWLAYDGYGFFKVFFVKDPTLAGWRRHRKPCDPTCAIRYQGLGRCLWFRDCGDPAALAERISGLPASHRGDVWSGVGLAATYANGVSPDDHALLLRLAGNHRPALAQGAAFAAEARRADGTAGPAVDAATRTLTGVSADTAAEWTWQARHGLDRAGATPADYGEWRARVQRLAARHVAG	MTKLRHATTGAFLAALATFAHAEHPVCTLVADAATGKVVLQEGKCNERVTPASTFKLALAVMGYDAGFLKDPHTPVEHFRRGDPDWGGRPWRQPVDPTLWLKYSVVWYSQRITHAMGAQMFASYVRKLDYGNMDVSGDPGKNNGLDRSWITSSLKISPEEQVGFLRRLVNRQLPVSAQTYEMVDRTVQTWQVPGGWAVQGKTGTAGPAPGNTSADGTWDQAHAYGWFVGWAKKGGRTYVFANLIQDDKIEPTSGGIRSRDAMLARLPQVLAAAKP	131.27	gnl|BL_ORD_ID|2259|hsp_num:0	3513			174	666	cloxacillin; oxacillin; cefalotin
BGC0001060.1|Dynemicin_15 # 17050 # 18948 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.738	BGC0001060.1|Dynemicin_15 	17050	18948	+	Loose	560	28.1054	OXA-459	24.5	3003615	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCCAGTCCCCACCGCGCCCGCAGGATCATCGCCCCGCTGCTGGCCGTCCTCATCGCCACGACCCTCGGGCTGGCCTCCCGGCTGCCGGACGCCAGCGCCGCCGACCGCCGGGCGCTGGCCGGGCGGTTCGCCTTCGACGTCGGCGACCTGAACGCCGACCCGGCCGGCGCCCGCACCCAGCGGACCGTGGAACCCGCCCTCGAACACCTGCGGGCGTGGATCTCCTCGGTGGGCGCCGGGGCGGCGCTGGCCGACCTCGACGGGGACGGCCTGCCCAACGACACCTGCCTCGTCGACCCCCGGGACGACTCGGTGAGCGTCACCCCGACCCCGGACCGGGCCACCCGCTACGCCGCCTTCCCCCTGCGCCCCACCGGGGTGCCCTACGACACGGGGATCACCGCGCCGATGGGCTGCGCGACCGCCGACCTCAACGAGGACGGCCGCCTCGATGTGCTCGTCTACTACTGGGGACGGGCGCCGCTGGCCTGGCTGCAACGCGCCGACGTGCCGTTCGGGCCGGCCGCGTTCACCGCCGTCGACGTCACCGACCGCCCCACCGAGCTGTGGAACAGCACCACCGCCAACGTGCTCGACCTGGACGGCGACGGCCACCTGGACATCGTGGTCGGCAACTACTTCCCCGACGGGGCGCGGGTGCTCGACGCGGCCGCGAAGGACGACCCGCGGATGCGGATGCAGGACTCGATGTCCTGGGCCCGCAACGGCGGGCGCAACCGGATCCTGCGCTTCACCGGCCTCACCCCCGTCGCCGGCGGCCCGGCCCGCCCCACCTACGCGGACGCCTCCGCGGCCCTCACCGACGAGCAGGCCCGCTCCTGGACCCTGGCCATCGGCGGCCAGGACCTGGACGGCGACAACCTGCCCGAGGTGTACGTGGCGAACGACTTCGGCCGCGACTACCTGCTGCACAACGTCTCGCAGCCGGGCCGGATCCGGTTCGCCGAGCTGCCCGGGCGGCGCGACGCCGACATGCCGAAGTCCAAGGTGCTCGGCAACGACTCGTTCAAGAGCATGGGCGTTACCTTCACCGACCTCAACGCCGACCAGCGGCCGGACATCCTGGTCAGCAACATCACCACCCCGTACGCGCTCCAGGAGAGCAACTTCGCGTTCGTCAGCACCGACGCCGCCCCGCTCACCGACCACGCTCCCTACCGGGACGAGAGCCAGCGGCTGGGCCTGGCCCGCACCGGCTGGGCCTGGGACATCAAGGTGGCCGACTTCGACGGCGACGGCACCGACGAGATCGTGCAGGCGCTGGGCTTCCTGCGCGGCACGGTGAACCGCTGGGCCGAACTCCAGGAGCTGGCCATGGGCAACGACGTGTTCCTCCAGTACCCGTACGCCTGGCCGAACTTCCGCGACGGCGACGACATCGCCGGGCACCAGCGCAACCCGTTCTTCGTGCGGGGCGACGACGGCCGGTACGTGGACGTCTCCGACCGGCTCGCCTTCCGGCAGCACGCCACCACCCGCGGCCTGGCCGTCGGCGACACCGACCACGACGGGCGGCTGGACCTGGTGGTGGCCAACCAGTGGGCCCGGTCGCAGTTCCTGCACAACACCGGCCCGGCCCGCGCCCACCTCGGGCTGCAACTGCTGCTCCCGGCCACCGTCCCCGGCGGGAAGCCGCGGCCCGCGGTCGGCGCGACGGTCCAGGTGCGCCGGGCCGACGGCACCGCGCTGACCGCCCAGCTCTACCCCGCCAACGGCCACACCGGCGGCAACTCCCCCGACCTGCTCTTCGGGCTCGGCGACTCGTCCGGCCCGGTCACCGCCACGGTGACCTGGCGCGACGCCGCCGGCCAGCACGCCATGACCAGGTCCCTGAACCCCGGGTGGCACACCCTCGTGCTCACCCCGACCGCGTAG	MPSPHRARRIIAPLLAVLIATTLGLASRLPDASAADRRALAGRFAFDVGDLNADPAGARTQRTVEPALEHLRAWISSVGAGAALADLDGDGLPNDTCLVDPRDDSVSVTPTPDRATRYAAFPLRPTGVPYDTGITAPMGCATADLNEDGRLDVLVYYWGRAPLAWLQRADVPFGPAAFTAVDVTDRPTELWNSTTANVLDLDGDGHLDIVVGNYFPDGARVLDAAAKDDPRMRMQDSMSWARNGGRNRILRFTGLTPVAGGPARPTYADASAALTDEQARSWTLAIGGQDLDGDNLPEVYVANDFGRDYLLHNVSQPGRIRFAELPGRRDADMPKSKVLGNDSFKSMGVTFTDLNADQRPDILVSNITTPYALQESNFAFVSTDAAPLTDHAPYRDESQRLGLARTGWAWDIKVADFDGDGTDEIVQALGFLRGTVNRWAELQELAMGNDVFLQYPYAWPNFRDGDDIAGHQRNPFFVRGDDGRYVDVSDRLAFRQHATTRGLAVGDTDHDGRLDLVVANQWARSQFLHNTGPARAHLGLQLLLPATVPGGKPRPAVGATVQVRRADGTALTAQLYPANGHTGGNSPDLLFGLGDSSGPVTATVTWRDAAGQHAMTRSLNPGWHTLVLTPTA	MTVRLSSCALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPASTFKLPIALMGADAGILTGPHAPVWNYQPDYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFHYGNEDVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLPVKAAAYDLAENLFEVGEAGGWRLHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK	229.82	gnl|BL_ORD_ID|2535|hsp_num:0	3526			165	561	cloxacillin; oxacillin; cefalotin
BGC0001060.1|Dynemicin_16 # 18978 # 19967 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=6bp;gc_cont=0.719	BGC0001060.1|Dynemicin_16 	18978	19967	+	Loose	580	27.7202	HERA-8	26.67	3004822	protein homolog model	n/a	n/a	penam	antibiotic inactivation	HERA beta-lactamase	GTGTCCGACAAGGCCACTCCCCGTACGGCGAACCGACCGGACCCACGGATCACGGCGCTGCGCCGGTTCGCGCTGTCCATCACCGTCTTCAACATCGTCGGGCACCTGCTGCTCGGGTTCGAGCAGGCGTACGTCACGCCGGTCGTGGCGGTGCTCATCGCGTACGCGGTGGACCTGCTGCTGGAGACCGTCGAGGCGCGCGCCACCGGGCGCCCCGAGCGCTACCGGGGCGGACCGGTGGCCCTGCTGAACTTCCTGCTGCCCGCCCACATCGCCGGCCTGGCCTGCGCCATGCTGCTCTACGGCAACCAGAGCCTGGCGCCCACCATGTTCGCCGCCGCGGTGGCGGTGAGCAGCAAGTACGTCATCCGGCTGCCGGTCCGCGGCAGCCTGCGGCACGTGCTCAACCCGAGCAACTTCGGCATCAGCGTCACGCTGATCCTGTTCAGCTGGGTCAGCATCGCACCGCCGTACCACTTCAGCGAGGACGTGGACGGGCCGGTCGACGTGGTGATCCCGCTGGTCATCCTGGCCGCCGGCACCATGCTCAACGGCAAGCTGACCCGGCGGCTGCCGCTGATCCTGGGCTGGGCCGGCGGCTTCGTCCTCCAGGCGGTGCTGCGCGCGGTGTTCTTCGACGCGCACCTGGCCGCCGCGCTGCTGCCGATGACCGGTATCGCGTTCATCCTCTTCACCAATTACATGATCACCGACCCGGGCACGACGCCGGCCGCCCCGCGCCGGCAGGTGGTGTTCGGCCTGGCCACGGCGGCCGTCTACGGGCTGCTGGTCCTCGCCCACATCACGTTCGGCCTGTTCTTCGCGCTGGTGATCGTCTGCGGCCTGCGCGCCCTGGTGATCCTCGGCGCCAACCTGCGCGACCGGGCGAACGGCACACCCGCGCTGAGCGCCGGCCGGCCCGCCGGGACCCCGCCGGCCGACGCGGCCCCCGTCGACGTGGGCCAGGTGCCGGTGCCCGCCGCCCGCTGA	MSDKATPRTANRPDPRITALRRFALSITVFNIVGHLLLGFEQAYVTPVVAVLIAYAVDLLLETVEARATGRPERYRGGPVALLNFLLPAHIAGLACAMLLYGNQSLAPTMFAAAVAVSSKYVIRLPVRGSLRHVLNPSNFGISVTLILFSWVSIAPPYHFSEDVDGPVDVVIPLVILAAGTMLNGKLTRRLPLILGWAGGFVLQAVLRAVFFDAHLAAALLPMTGIAFILFTNYMITDPGTTPAAPRRQVVFGLATAAVYGLLVLAHITFGLFFALVIVCGLRALVILGANLRDRANGTPALSAGRPAGTPPADAAPVDVGQVPVPAAR	MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGYRQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISLRMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDPVTRLDRTEPTLNEATPGDARDTSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGGYGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANEAIPAIGKQLFAGQP	113.45	gnl|BL_ORD_ID|2567|hsp_num:0	3616			132	357	
BGC0001060.1|Dynemicin_17 # 20001 # 25703 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.790	BGC0001060.1|Dynemicin_17 	20001	25703	+	Loose	750	93.5893	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	31.1	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGGTCGACGACGACGTGGTGATCGTGGGCCTGGCCTGCCGCTACCCGGCGGCGGACAACCCGACCCAGCTGTGGGAGAACGTCCTCAACCGGCGGCAGGCGTTCCGGCCGCTGCCGGCGGGCCGGCTGCCGCTGGCCGAGTACGGCGGCGACGGCCCCGACCGGACCACGGTCCGCCGGGCCGCGGTACTGGACGGCTGGCGCTTCGACCGGGCCCGCTTCCGGATCCCGGGCAGCACCTTCCGGGCCGTGGACCTGTCCCACTGGCTGGCGCTGGAGACCGCCGCGGACGCCCTTGTCGACGCCGGCCTGCCGGACGGGACCGGCACCGACCGGTCCCGGGTCGGCGTGGTCATCGGCAATTCGCTGACCGGCGAGTTCTCCCGGGCCGCCGGCCTGCGGATCCGCTGGCCCTACGTGCGCCGGGCGGTCGCCGCCGGCCTGGTCGACGGAGGGCTGGCGACCGACGAGGTCGCGGCGCTGCTGGACCGGGTGGAGGAGCGGTTCAAAGCGCCGTTCCCGGTGCCCGGCGACGAGACCCTGGCCGGCGCGCTGGCAAACACGATCGCGGGCCGCATCTGCAACCAGTTCGACTTCCACGGCACCGGCTACACAGTGGACGGCGCCTGCGCCTCGTCGCTGCTCGCGGTGATCACCGCGGCCGAGGCGGTGGCCGCCGGCCAGCTCGACGTGGCGCTGGCCGGCGGGGTGGACCTCAGCCTCGACCCGCTGGAGCTGGTCGGCTTCTCCCGGGTCGGCGCGCTGGCCGGCGACGAGATGCGGGTGTACGACGCCCACCCCACCGGCTTCCTGCCCGGCGAGGGCTGCGGCGTGGTGGTGCTGGCCCGGGCCGGGTACGCGCGGGAGCGGGGGCTGCGCCCGTACGGGCGGCTGCTCGGCTGGGCGTCCTCGTCGGACGGCAGCGGCGGGCTGACCCGGCCGGAGGAGAGCGGGCAGCGGCTGGCGCTGCGCCGGGCGTACGACCGGGCCGGCATCGAGCCCGGCGCGGTCCGGCTCGTGGAGGGGCACGGCACCGGCACCGCCGTCGGCGACGAGGCGGAACTGCGGGCGCTGCTCGGCGTACGCGGGCCGGCCGCGTCACCGGCGGTGCTGGGCAGCATCAAGGCGAACATCGGGCACACCAAGGCGGCGGCCGGGGTGGCCGGGCTGATCAAGGCGGTGCTGGCCGTGCACCGGGAGGTGCTGCCGCCGACCACCGGCTGCCACCGGCCGCACCCGCTGCTCGCCGAGGGTGGCGCCCTGCGGGTCACCGACGAGGCCCGGCCCTGGCCGGACGGCGAGCGGTACGCCTCGGTCAGCGCGATGGGCTTCGGCGGGATCAACACGCACGTGGTGCTCGGCGGGACGGCTCCGTCGGCGTCCCGGCCGCTCAGCGCGCACGTACGACGGTTGAGCCGGCCGCACCCCGACCACGAGCTGGTGGTCTGCGGGGCCCCGGACGCGGCGGCGCTGACCGGGCTGCTCACCCGGGTCCGGGCGGCGGCCACCGCGCTGTCCCGCCCCGAGCTGACCGACCTGGCCGCCGGGCTCGCCGCCGCCCACCGCGGGGACGTCCCGGCCCGGTTCGCCGCGGCCGTCCGCGACGCCGACGGGCTGGTCGCCGCCCTCGACCGGGCGCTCGGGCACCTGGCCGAGGGCGGCCGTCGCCTGCTGGACGCGGGTCGCGGGCTGTTCCTCGTGGTCGGCGGGCCGCTGCGGGTGGGGCTGCTCTTCCCCGGCCAGGCCGCACCGGTGCACGCCGACCGGGGCGCGCTGGGCCACCTGCTCGGCGACGCGGACGCGGGAACCGGCTCCGACCCCGATTCCGGGGTGAAGCCGGCGGAACCGGTCGACACGGCGGTGGCCCAGCCGGCCATCATCGCCGACAGCCTGGCCGGGATCCGCTGGCTGGACCGGCTCGGCGCCCGGCCGGTCGGCGCGCTCGGCCACAGCCTCGGCGAGCTGGCCGCGCTCAGCTGGGCCGGTGCGCTGGACGCCGACGACACCCTGGCCCTGGCCCGCGCGCGCGGCGAGGCCATGTCCGCCGCGACCGAGGCGCCCTCCGGGATGCTGTCGCTCCGGGCCGACCTGGCCGCCGCGCGGGAACTGGCCGCCGGGACCGGCGCGGTGGTGGCCGTGGACAACGGCGAGAGGCACGTGGTGGTGGCCGGCACCCGGCCCGAGCTGGACCGGGTCGCCGAGGCCGCGCGGCACGCCGGGATCGAGGCGACGCCGCTGGCCGTCTCGCACGCCTTCCACTCCCCGCTGATGGCCCCGGCCGCCGAGGCGCTGCGCCGGGCCGCCGGGCGGCTCCCGTGGCGGCGGCCCGAGCGGCCGGTGGCGTCCACGGTCACCGGGGCGTGGTGGGCCGACGAGGACCCGGTCGAGGTGCTGGTCCGGCAGCTCACCGGGCCGGTCCGGTTCCGCGAGGCGCTCGGCCTGCTCGACGCCGACCTGCTCGTTGAGGTCGGCCCCGGGCGGATGCTCAGCGCGCTGGCCGAGGCGGCCGGGCGTACCGCGGTCAGCCTGGACGCCGGCGCGGCGAGCGCGGCGGGCATGGCCGCCGGTACCGCGGCGCTCTTCGCCGCCGGCGCTGTCGACGACGCGACGCCCTTCTTCGCCGGGCGCTTCACCCGCCCGTTCGACAGGGACCGGGAGCGGGAGTTCCTGGTCAACCCGTGCGAGCGGGAGGTGCCCGCGGTGGCCCTGCCGGCGCCCCGCGCCGCGACGCCGGACCCGCGCCCCCGGGCGAGCGCCGGGCCGGTCGCGGCCCGCCCGGCCGACGGCCGGGGCACCGCCGAGCTGGTCGCCGCCCGCGTGGCCGACCTGGCCGAGCTGCCGGCCGCCGAGGTGGGCCCGGGCACCCGCCTCCTCGCCGACCTGCACCTGAACTCGATCCGGGTCGGCCAGCTCGCCGCCGAGATCGCCGGGGAACTGGGCCGGGCGCTGCCCGCCACGCCGCTGTCCCTGGCCGACGCCACGGTGGGCGAGTTCGCCGCCGCGATCGAGGGGCTGCCGACCGCCGACGCACCCGCCGCCGAGCTGCCCGCCGCCGGCGTCGGCCCCTGGGTCCGGGTGTTCCGCCACCACCTGGTGCCCCGACCGGCCGGTGCCGCCGCCCCCGCCGGCGAGCCGCCCGCCTGGGAGGTGGTCGGCCCGCTGGCCGGGCACCCGCACGCCGAGGCGGTGCGGACCGCGTTCCGGGTGGACGCCGGGGCGCCGGCGGGCCGGCTGCTCGCCCTGCCGCCAGGGCTGGCCGACATCCCGACCGCCGACGTGGTCGCCGCGCTGCGCGCCGCGGCGGGCGACCGGCGGCCGCTCGTGGTGCTGCACCACGGCGGGGTCGGCGCGGCCGTCGGCCGCAGCCTGGCCGTGGAGACCGGAGCGCCGGTGCTGGTGGTGGAGACCCCGCCGGGCCCGGCCGGCGTCCGGCTGGCCGCCGTCGAGGCGTCCCGGCCGTGGTCCGGCTACCAGGAGGTCGTGTACGGCGCGGACGGCGTACGCACCGTGCCGGTCACCCGGCTGCTGGACGGGCAGCCCCGCACCGACCGGCGGATCCCGCTCGGCCCGGGCGAGGTCTGCCTGGTCACCGGGGGCGCGAAGGGGATCGGGGCGGCCTGCGCGGCGGCCCTCGGCGAGGCCACCGGGGCGCGGCTCGTGCTCTTCGGCCGCAGCCCCGCCGACGATCCGGAGGTGGTCGAGGCGGTCCGCCGCACCGGCGCGGTCTACCGGTCGGTCGACCTGGCCGACCCGGTGGCGGTGGCCGCGGCGGTCACCGCCGTCCGCGCCGAGCACGGCCCGGTGCGCGGCCTGCTGCACGCGGCCGGGCGCAACGAGCCGGCGCCGGTGACCGACCTGACCGCCGAGGAGCTGCACCGCACCCTCGCCCCGAAGGCGTACGGCTTCGAGCACGTGGTGGCCGCGCTCGACCCCGACGAGCTGCGCTTCGCCGTGGCGTTCGGCTCGGTGATCGGCCGCGCCGGACTTCCCGGCGAGGCGGCGTACGCCACCGCCAACGAGTACCTCTCCCGGCGCTGCGCGGAGCTGGCCGCGACCGTGCCGCAGGTGCGCTGGCTGAGCATCGAGTGGTCGGTCTGGTCCGGGACCGGGATGGGCGTCCGGCTCGGCGTGCTCGACGGGCTGCTGCGGCGCGGGGTCAGCCCCATCCCGCCCGACGAGGGCACCCGCCTGCTGCTGGAACTGCTCGCCACGCCGGCGCTGCCGCCGGTGGTGCTGGTGGCCGGCCGGCTGCCGGTGAGCGACACCCTGGAGTGGGACGAGTGCGCCGAGGAGCACGGCCGTTTCCTGGAGTCACGGCTGGTCGGCACGCCCTGCGTCGAGCTGGTCAGCGAGGCCCGGCTCTCCCTCGGCGCCGACCCCTACCTGGACGACCACCGGATCGACGGCGCGGCGGTGCTCCCGGCCGTGCTCGGGCTGGAGGCCATGGCCCAGGCCGCCGCCGCGCTCGGCGCGAAGCAGGTGCCCACGGTGATCCGGGACGTGGCGCTGACCCGCCCGGTGACGGTCGGCGACCGGGAGCCCCGGCCGGTCCGGGTGGCCGCGCTGACCGGCGCCGACGGCACCGTCCGGGCGGCGGTGCGCAGCGCGGAGACCGGCTTCGCCGTGGACCACCTCACCGGCACGTACGGCGGGGCGGTGACCTCGGGCGAGCCGGTGCCGCCGCCCTCCACCGGGCTGCTGGTGCCCGGCGGGCCGCTCTACGGCCCGGCCTTCTTCCACGGCCCCCGGTTCCGGCGGGTGGCCGGCTACCACGGGCTGAGCGCCTACCGGTGCGTGGCGGAGGTGCACGCCGAGGCGGGGACCTGGTTCGGCGGTTTCCACGACCAGCGGCTGCAACTGGGCGACCCGGGGGTGCGGGACGCCTTCCTGCACCTGCTCCAGGCGTGCGTGCCGGACCGGCGGGTGCTGCCCGTCGGGGTGGACCGGATCGACATCCACGCCCGCCCGGAGGGCACCCTGACCGTCCACGCCCGGCAGGTGGCCGAGGCGGGCGACGAGTTCCGCTTCGACGTCACAGTCATCGACGCGGACGGCTCGCCGGTGGAGCGCTGGACCGGGCTGCGGCTGCGCGCGGTCGGCCCGGTGGAGAACGCCGTGTGGCCGGCCGAGCTGGTCGGGCCGCTGGTGACCCGGCGGCTGCGCCGCTGGCGGCCGGAACTGCGGGTGGACCTGGCCGCCGCGCCGGCCGGGCGGGGCGACCGGGAACGCAGCCGGGCGCTGGCCGGCTGGCTGCTCGGCGGCGAGGTACGCGCCGACGCCACCGGCCGGCTCCGGCCCGGCGTACCGGCCACGCCGCTGGGGTGGCGCGGGATCAGCGTCAGCCACCTCGACGGGCACCTGCTGACCGCCGCGGCGGACCGCCCGGTCGGGGTCGACTGGGAGGTCGTCACCCCCACCCCACCGTTGCCCGAGGCGGCGGCGCGGGTCGCCGAGGCGCTGGCCCGGCTCACCGGCGAGGACGCGGCCACCGCCGGCACCCGGGTGTGGACGGCGCTGGAGGCGCTGGTGAAGGCGGGCGCCGCAGTCGACGTACCGCTGGTGCTGCGCGACGAGACCGGGCCGGACGGCTGGGTGGCGCTGCACGCCGGCCGGCACGCGGTCTACGGGACGGTCGTGCCGGCGACACCCGGGCCGATCGCGGTGAGCCTGGCCGTCGCCGTGGACGCCGACGGGGAGGGGTGA	MVDDDVVIVGLACRYPAADNPTQLWENVLNRRQAFRPLPAGRLPLAEYGGDGPDRTTVRRAAVLDGWRFDRARFRIPGSTFRAVDLSHWLALETAADALVDAGLPDGTGTDRSRVGVVIGNSLTGEFSRAAGLRIRWPYVRRAVAAGLVDGGLATDEVAALLDRVEERFKAPFPVPGDETLAGALANTIAGRICNQFDFHGTGYTVDGACASSLLAVITAAEAVAAGQLDVALAGGVDLSLDPLELVGFSRVGALAGDEMRVYDAHPTGFLPGEGCGVVVLARAGYARERGLRPYGRLLGWASSSDGSGGLTRPEESGQRLALRRAYDRAGIEPGAVRLVEGHGTGTAVGDEAELRALLGVRGPAASPAVLGSIKANIGHTKAAAGVAGLIKAVLAVHREVLPPTTGCHRPHPLLAEGGALRVTDEARPWPDGERYASVSAMGFGGINTHVVLGGTAPSASRPLSAHVRRLSRPHPDHELVVCGAPDAAALTGLLTRVRAAATALSRPELTDLAAGLAAAHRGDVPARFAAAVRDADGLVAALDRALGHLAEGGRRLLDAGRGLFLVVGGPLRVGLLFPGQAAPVHADRGALGHLLGDADAGTGSDPDSGVKPAEPVDTAVAQPAIIADSLAGIRWLDRLGARPVGALGHSLGELAALSWAGALDADDTLALARARGEAMSAATEAPSGMLSLRADLAAARELAAGTGAVVAVDNGERHVVVAGTRPELDRVAEAARHAGIEATPLAVSHAFHSPLMAPAAEALRRAAGRLPWRRPERPVASTVTGAWWADEDPVEVLVRQLTGPVRFREALGLLDADLLVEVGPGRMLSALAEAAGRTAVSLDAGAASAAGMAAGTAALFAAGAVDDATPFFAGRFTRPFDRDREREFLVNPCEREVPAVALPAPRAATPDPRPRASAGPVAARPADGRGTAELVAARVADLAELPAAEVGPGTRLLADLHLNSIRVGQLAAEIAGELGRALPATPLSLADATVGEFAAAIEGLPTADAPAAELPAAGVGPWVRVFRHHLVPRPAGAAAPAGEPPAWEVVGPLAGHPHAEAVRTAFRVDAGAPAGRLLALPPGLADIPTADVVAALRAAAGDRRPLVVLHHGGVGAAVGRSLAVETGAPVLVVETPPGPAGVRLAAVEASRPWSGYQEVVYGADGVRTVPVTRLLDGQPRTDRRIPLGPGEVCLVTGGAKGIGAACAAALGEATGARLVLFGRSPADDPEVVEAVRRTGAVYRSVDLADPVAVAAAVTAVRAEHGPVRGLLHAAGRNEPAPVTDLTAEELHRTLAPKAYGFEHVVAALDPDELRFAVAFGSVIGRAGLPGEAAYATANEYLSRRCAELAATVPQVRWLSIEWSVWSGTGMGVRLGVLDGLLRRGVSPIPPDEGTRLLLELLATPALPPVVLVAGRLPVSDTLEWDECAEEHGRFLESRLVGTPCVELVSEARLSLGADPYLDDHRIDGAAVLPAVLGLEAMAQAAAALGAKQVPTVIRDVALTRPVTVGDREPRPVRVAALTGADGTVRAAVRSAETGFAVDHLTGTYGGAVTSGEPVPPPSTGLLVPGGPLYGPAFFHGPRFRRVAGYHGLSAYRCVAEVHAEAGTWFGGFHDQRLQLGDPGVRDAFLHLLQACVPDRRVLPVGVDRIDIHARPEGTLTVHARQVAEAGDEFRFDVTVIDADGSPVERWTGLRLRAVGPVENAVWPAELVGPLVTRRLRRWRPELRVDLAAAPAGRGDRERSRALAGWLLGGEVRADATGRLRPGVPATPLGWRGISVSHLDGHLLTAAADRPVGVDWEVVTPTPPLPEAAARVAEALARLTGEDAATAGTRVWTALEALVKAGAAVDVPLVLRDETGPDGWVALHAGRHAVYGTVVPATPGPIAVSLAVAVDADGEG	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	456.73	gnl|BL_ORD_ID|1968|hsp_num:0	1943			507	1242	isoniazid
BGC0001060.1|Dynemicin_18 # 25708 # 26142 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.724	BGC0001060.1|Dynemicin_18 	25708	26142	+	Loose	700	28.8758	ADC-220	37.78	3006389	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGCCCGACAGCTACGTCCACCGGCACGTGGTGACCTTCGACGAGACGAACCTCGTGGGGAACGTCTACTTCGCCCACTACCTGCACTGGCAGGGCCACTGCCGGGAGCACTTCCTGGCCGACCACGCGCCCGGCGTCATGGCCGCGCTGGCCGACGGGCTGGCCCTGGTGACCGTCGACTGCCACGCCGACTTCTACGCCGAGGGCAGCGCCTTCGACGAGGTCGAGGTGCGGATGATGCTGGACCGGCTGGACGGCCACCGGATCGCGATGTCCTTCGACTACGTCCGGGTGGCGCCCGGCCCGCCGACGCTGCTGGCGCAGGGCCGGCAGACGGTGGCCTGCATGCGCCGGGCCGGGCACGGCCTGGAACCGGTCGAGGTGCCGGCCGAGCTGCGCCGGGCGCTGAGCCGGTACGCGGTGGTGGCCCGATGA	MPDSYVHRHVVTFDETNLVGNVYFAHYLHWQGHCREHFLADHAPGVMAALADGLALVTVDCHADFYAEGSAFDEVEVRMMLDRLDGHRIAMSFDYVRVAPGPPTLLAQGRQTVACMRRAGHGLEPVEVPAELRRALSRYAVVAR	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALKFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYDFGYNQENQPIRVNPGPLDALAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	37.60	gnl|BL_ORD_ID|3218|hsp_num:0	4285			699	834	
BGC0001060.1|Dynemicin_19 # 26139 # 26798 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGTGG;rbs_spacer=7bp;gc_cont=0.791	BGC0001060.1|Dynemicin_19 	26139	26798	+	Loose	200	34.6538	vanH gene in vanB cluster	28.92	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGACCGTCGGCATCGTGGGCCGGGGCCGGATGGGCCGGGGCCTGGCCGAGGCGGTCCGGCAGGCCGGCCTCCACCCCCTCCTGGTGCCGGGCCGGGCCGACCCGCGCCGGGTGGCCGACCTGCTCGACCGGGCCGCGCTTGTGGTGCTCGCGGTGCCGTTCCCCGCCGCGGTCGAGTTCCTGCGGGGCCCGGCCGGGCGGCGCGGCCGGGGTCGCACCCTCGTCGACCCCACGAACCCGGTGTTCTGCGAGCCGCCGGTGGTGCCGCCCGGCCGCTCCGGCGGCGAACTGCTGGCCGAACTCGCCGCCGACCGGGCCTCCGGCCCGGACCATCCGGGCGAGGGCTGGCGGGTGGCGAAGGCGTTCAACACGGTGCCGGCCGGGGTGCTGGCCCGGTGCCGGGTCAACGGCCTGCCGGTGTCGCTGCCGGTCGCCGCCGACCATCCGGCGGCGCTGCGGGACGTCTTCGCGCTGGCCCGGGCACTGGGCTTCGCGCCACTGGACGCCGGGGGCATCCGCACGGCCCGCCACCTGGAGGCGCTGACCGGGCTGCTGATGGCGGTCAGCGACCGGCAGGGCCTGCGCGGCCAGGTGTCCATCCACATCGGCGTGCCGAGCGGCGACCGGACCGTGTGGGAGCCGGCGTGCCGGGCCGGCTGA	MTVGIVGRGRMGRGLAEAVRQAGLHPLLVPGRADPRRVADLLDRAALVVLAVPFPAAVEFLRGPAGRRGRGRTLVDPTNPVFCEPPVVPPGRSGGELLAELAADRASGPDHPGEGWRVAKAFNTVPAGVLARCRVNGLPVSLPVAADHPAALRDVFALARALGFAPLDAGGIRTARHLEALTGLLMAVSDRQGLRGQVSIHIGVPSGDRTVWEPACRAG	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	67.80	gnl|BL_ORD_ID|4673|hsp_num:0	626			441	690	vancomycin
BGC0001060.1|Dynemicin_20 # 26804 # 27478 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.720	BGC0001060.1|Dynemicin_20 	26804	27478	-	Loose	300	31.187	dfrA29	35.53	3004554	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGGGCTGCTGAAGGACCGACGCACCTACGACCAACAGTGCGGACTGGCCTATGCGCTGGACGTTCTCGGCGAACGCTGGACTTTGCTGATCGTCCGGGAGCTGCTGATCCGGCCCCGTCGCTACGGCGAACTCCTCGATGCTTTGCAAGGAATCGGCACCAACCTTCTGGCCGACCGGCTCGGCTTCCTCGTCGAAGCGGGGCTGGTCCGGCCGCTCGATCCGCAGCGGCGGACCGCGGGCTACGCGCTGACCGAGTTGGGTGAGCGGATGCGGGAGCCGGTGCTGAGCCTGGCCCGGTTCGGCCTGACCTACGCCGCCCACCAGCCGCCGCCGGCCGCTTCGGTGACCCGGCCGGCCTGGGCGATCCTCGCCACCGACGCGATGCTCGACGACACCCGCGCCCCCGGGATCGACGAGGTCTACGGCTTCGACGTCGACGGCGAGCAGTTCCACGTCGTGGTGGAGGGCGGCCGGGCGGTCCTGCACCCCACCGCCGCGCCCGACGCGACACTCCACGTGAAGACCGACGCGAAGACCTTCTTCCAGCTCGGGGTGCGGCGGCTGGACCCGCTGGAGGCGGTGCTCGCCGGCTCGGTGCAGGTCTCCGGGCCGCCGGCCGCCATGTCGCGCTGCCTGCGGCTGCTCGGCCTGGCCGGCAACCCGCTCGGCTGA	MGLLKDRRTYDQQCGLAYALDVLGERWTLLIVRELLIRPRRYGELLDALQGIGTNLLADRLGFLVEAGLVRPLDPQRRTAGYALTELGERMREPVLSLARFGLTYAAHQPPPAASVTRPAWAILATDAMLDDTRAPGIDEVYGFDVDGEQFHVVVEGGRAVLHPTAAPDATLHVKTDAKTFFQLGVRRLDPLEAVLAGSVQVSGPPAAMSRCLRLLGLAGNPLG	MAARAKNGVIGCGPNIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGPLPNRKYAVVTRSNWTAANENVVVFPSIDEAMGRLGEITDHVIVAGGGEIYHETIPMASTLHVSTIDVEPEGDVFFPNIPGKFDVVFEQQFTSNINYCYQIWQKG	147.37	gnl|BL_ORD_ID|2708|hsp_num:0	3262			123	336	trimethoprim
BGC0001060.1|Dynemicin_21 # 27548 # 28471 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.739	BGC0001060.1|Dynemicin_21 	27548	28471	+	Loose	1500	27.7202	rphB	33.85	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGACCGCCCTCGCCAGCTCCACTCGTACCGAAGTTCCCACCACCCGGCGCCGCCCGGTCGCCGCCGTCGCCGGCGTGCTCGGCGGCCTGGTGCTCGCCGTGCTCTGGTCGTTCGAGTTCGTCGACCACGTGATCGGCGACAACGTCGCCAACTCGGTGCTCGGCACCGACGCCAAGCAGACCGCCATCGCCGGCTCCGCGGCCGGGGTGGTCTTCGCCTTCGTCTCCGGGTTCGCCGGAACGTTCACCGCCTGCAACATCGCCGTGTTCGGCGCGCTGCCGGACGTCGCCGAGTGCTCGGCCGCGCCCCGCCGCGGCCGGCTGGCCGCCGCGCTGGCCCCGCTGGGCTGGCTGGCCCTCGGGCTGGTGTCGGTGGCCGCCGTGTACGGCTTCCTGGCCGTCCTCGTCGGCTCCCGGCTGCCGCAGCTCTCCACGGACACGGTCGGCGACGGCCTCCCGGTCCGGCTGGTCCAGGCGTCCGTGGTGTTCGGCGTGATCGGGCTGGCCTTCGCCTGGCTCGGGCTGGCCGCCCTGGGCCTGCTGCCCGACCCGTTCGCCGGCCGGCCGGTGGCCCGGCTCGTGACGCTTGGCGCGCTCGTCGGCGGCTTCCTGGTGGGCCGCCCGTACCCGCTGTTCCACAAGTTGCTGGAGCAGGCCGTGGACAGCCACAACCCGTTCTACGGCGCGCTCGTGCTGGTGCTCCAGTCGCTCGGCAACGTGCTCATCATGGCGGTGCTGGCCCTGCTGCTGGTGCTCGGCACCCGGGGCGCGTTCCAGCGCTGGCTGTCCCGCCCCGGCCGGGCCGCCCTGCTCGTCGGGGTCAGCCTGCTGGCGCTCGGCGCGTTCCTGGTCTTCTACTGGGACGTCCGGCTGCCGGCCATGTTCGGCTACGGCTGGTTCCCGACCATGCCGTGGAACGCCTGA	MTALASSTRTEVPTTRRRPVAAVAGVLGGLVLAVLWSFEFVDHVIGDNVANSVLGTDAKQTAIAGSAAGVVFAFVSGFAGTFTACNIAVFGALPDVAECSAAPRRGRLAAALAPLGWLALGLVSVAAVYGFLAVLVGSRLPQLSTDTVGDGLPVRLVQASVVFGVIGLAFAWLGLAALGLLPDPFAGRPVARLVTLGALVGGFLVGRPYPLFHKLLEQAVDSHNPFYGALVLVLQSLGNVLIMAVLALLLVLGTRGAFQRWLSRPGRAALLVGVSLLALGAFLVFYWDVRLPAMFGYGWFPTMPWNA	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	34.73	gnl|BL_ORD_ID|2235|hsp_num:0	2528			1620	1803	rifampin; rifaximin; rifabutin; rifapentine
BGC0001060.1|Dynemicin_22 # 28435 # 30318 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.777	BGC0001060.1|Dynemicin_22 	28435	30318	-	Loose	400	37.3502	vanR gene in vanD cluster	34.15	3002923	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGGTGCTGCCGTGGACACTGTGCGGATAAAGGTGTTGGGCCCGGTCGCCGCGTTCCGTGACACCACCGAGATCCCCCTGGGGCCGTCCCGGCAGCGTGCGGTCCTCGGCTACCTCGCCCTGCACCCCGGGCAGCCGGTCCCGGTCGGCGCGCTCACCGAGGCGGTCTGGGGCGACGACGCCCCGGCCAGCGGCGACCAGCTCGTCCGGACGTACGTGGCGCGGCTGCGCCAGGTGCTGGAGCCGGACACCGCGCCGCGCGCCCGGACCAACGTCATCGCCTCGGTGCCCGGCGGCTACCGGCTCGACGTGCCGCCGGACCGCGTCGACGCGTCGCACTTCCAGCAGCTGCTCGGCCGGGCCCGGGCCCGGCAGGCGGCCGGCGCGCCGCACGAGGCCTTCGAGCTGCTCGACGCGGCGCTCGGGCTCTGGCAGGACCCGACCCTCGCCGACCTCAGTGGCCTGCTGGCCAGCCCCCGGCACCTCACCGCGCTGCGCGCCGACTGGGTCGATGCCGGCCTGCGCCACGTCGCCGTGGGGCTGAGCCTCGGCCAGGCGTCGGTGGTGCTCCCGGTGGCCGAGCAGCTCGCGGCCGTCGAGCCGCTCCAGGAGGCGGTGCAGGCCCGCTACCTGGAGGCGTTGACCCGCAGTGGGCAGCGGGCCGCCGCCGTGCACCACTACCTGAGCGTCCGGGCCCGGCTCCGCGCCGAACTCGGTGTCGAGCCCGGTCCGGAGCTGCGCCGGATGTACGCCGCCCTGCTGCACGCCGGGGACGAGCCGGGGCCGGGCGTCGAACCGCCGTCCCGGGCCGGGGCGGACGAACCCGACCGGCGGCCCGGCTGGCGCGGACCCGGCCCGGCGATCGGCCCGCTGATCGGCCGGGAGGACGACGTCGCCCGCTGCGCCACGCTGCTCGTCGCGCACCGGGCCGTCACCATCGTCGGGCCGGCCGGCTGCGGCAAGTCGGCCACCGGGCTGGCGGTCGCCGAACGCGTCGCCGCCGCGTTCCCCGACGGCGTGGCCACTGTCGACGCGGCCGAGGCCCGGGACTGCGGCGAGGTGCTGCGGCTGCTGGCCGAGACGCTGGAACTGCCGGGGCCGAACGCCGACCCGCTGCGCGCCGTAGCCGACAAGCGGATGCTGCTGGTGCTCAACGACGTCGAGCACCTCGGCTCGCGGGCCGGCGAGATGGTGGAGCATGCCCTGCACCGCTGCCCGCGCACGGCCATGCTGGTCACCTCCCGCCGCCGGCTCGGGCTCGCCCACGAGGCGGTGTTCCGGCTCGCACCCCTGCCGCTGCCCGGGACCGATGCCCCGGACGCGCTGCCGGACAACCCGGCCGTGCGCCTCTTCGTCCACCGGGCCGGGCTGGTCCGGCCCGGCTTCCGCCTCGCCCCGGCGGACGCGGTGACCGTGGCGCGTATCTGCCGCGGGCTGGACGGCCTGCCGCTGGCCATCGAACTGGCCGCCGCCTGCCTCTACACCGACAGCCTCGACGGGGTGCTGCGCCGGGTCGACGACCCGCTGGACGAGTTGCGGCCACAGCGGCGCGGCCATCCGCAGCACCACCGTTCGCTGCGCGCCGCGCTGCACCGCAGCCTGGCCGCGCTCGCCCCGGTCGAGAGGGCCTGCCTGGCCCGCCTGGCCGCCGGTGACCGGTGCTTCTCGCGCGACGAGGCGGCCGCCCGCTGCGCCGGCCTGGTCCCGCCGGCCCGGCTCGGGGCCGTGCTCGACCGGCTCGTCGACGAGTCCCTGCTGGACGCCCGGCCCGGGCCGGGCGTCCCGCGGTACCGGCTCCTCCGCACGGTGGCGCTGGCGGCGGCCACCGTGCCGGAGAGCGGGGAGCATCAGGCGTTCCACGGCATGGTCGGGAACCAGCCGTAG	MGAAVDTVRIKVLGPVAAFRDTTEIPLGPSRQRAVLGYLALHPGQPVPVGALTEAVWGDDAPASGDQLVRTYVARLRQVLEPDTAPRARTNVIASVPGGYRLDVPPDRVDASHFQQLLGRARARQAAGAPHEAFELLDAALGLWQDPTLADLSGLLASPRHLTALRADWVDAGLRHVAVGLSLGQASVVLPVAEQLAAVEPLQEAVQARYLEALTRSGQRAAAVHHYLSVRARLRAELGVEPGPELRRMYAALLHAGDEPGPGVEPPSRAGADEPDRRPGWRGPGPAIGPLIGREDDVARCATLLVAHRAVTIVGPAGCGKSATGLAVAERVAAAFPDGVATVDAAEARDCGEVLRLLAETLELPGPNADPLRAVADKRMLLVLNDVEHLGSRAGEMVEHALHRCPRTAMLVTSRRRLGLAHEAVFRLAPLPLPGTDAPDALPDNPAVRLFVHRAGLVRPGFRLAPADAVTVARICRGLDGLPLAIELAAACLYTDSLDGVLRRVDDPLDELRPQRRGHPQHHRSLRAALHRSLAALAPVERACLARLAAGDRCFSRDEAAARCAGLVPPARLGAVLDRLVDESLLDARPGPGVPRYRLLRTVALAAATVPESGEHQAFHGMVGNQP	MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDIDGFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYMRYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVSTEELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK	270.26	gnl|BL_ORD_ID|1052|hsp_num:0	1004			465	693	vancomycin; teicoplanin
BGC0001060.1|Dynemicin_23 # 30429 # 31790 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5bp;gc_cont=0.747	BGC0001060.1|Dynemicin_23 	30429	31790	+	Loose	700	28.1054	ADC-42	21.67	3003873	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGCTCCCGGAGAACCCCCTCCCCGGCGACCGCCCCGCCGGACTCTCCCGCACCATCCCCCGCCAGTCCCGCCTGGCCCTGGCCACCCGTGGCGCGTTCGTGGTGGCCAGCAGCGCCGCACACCTGCTGCCCGCGGCGGCCGGCGCGGCGGTGCTGCGACCCCTGCGCGGCCGCACCGCGGCGGCCCGCTTCTTCTACCGCCGGCTGGTCCGGCACCTGCAACGACTCGGCCCGGCGCCGGTCAAGTTCGGCCAGATCATGGGCACCCGGCGGGACCTCCTGCCGCCCCTGCTCTGCGACGAGCTGGGCCGGCTGCACGACCGGGTCCGGCCGATGTCCGGCCGGCAGGTGCGCCGCGCGCTGCGCGAGGCGTACGGGCCGGACCTGAGCCGGCACTTCACCGAGGTCGAGACGACGGCGCGGGCCAGCGGCAGCATCGCCGGCGTCTACCGGGCCGTCCGGCCGGACGGCCGGGAGGTGGCGCTGAAGCTGCAACGCCCCGGCATCCGCCGCCGGATGGCGCTCGACCTGGCCCTCATCCACGGCGCGGCGGCGCTGGCGGAGAAGCTGCCGCCGGGCCGCGGGGTGCCGCTGGCCGAGCTGACCGGTTTCGTCTGCGCGGCAGTGCTCGGGCAGCTCGACTTCGCCGGCGAACGGACCAACCTGGCCGAGCTGCGGCGCAACTTCGCCGAGTCCGACAACGTGTGGATCCCGGCGACGCTCCCGGAGCTGTGCCGGCCCAACTGCCTGGCCATGGAGTTCATCCCGGACCTGGTGGCCCGCCCGGTCGCCGAGATCGATCCGGCCCGCCGGCCCCGGCTGGCCGCCCGCACCGTGAGCGCGGTCTACCAGATGCTCTTCCTGGACGGCTTCGTCCACTGTGACCTGCACCCGGGGAACGTCTACTTCAAGGGACCCCGGGTGGTCGTGCTGGACGCCGGGTTCAGCATCCGGCTCGACCCGACCGTACGCCGGCAGTTCGCCGACTTCTTCCTCGGCCTGGCGCTGGGACGGGGCCGGCAGTGCGGCGAGGTGGTGGTGGACAGCGCGGTCCGGGTGGCGCCCGACGCGGACGTCGACGGCTTCATCGGCCGGGTCGCCGAGCTGGTCAAGCGGAACACCGGGGTGCCGGCCAAGGAGTTCCAGCTCACCCGCTTCGGCACCGAACTGTTCACCCTGCAACGGGACTTCGGCCTGTACGCCGCGTCCGAGTTCGTCTTCCCGCTGCTGTCGCTGCTGGTGATCGAGGGGACCGTCCGCGACCTCGACCCCGACATCGACTTCCAGGCGGCGGCCCGCCCGATGCTGCTGCGCGCCGCCGCCGAGACCGCCCACCTGGCCCCGCAGCGCCGGGCCGGCTGA	MLPENPLPGDRPAGLSRTIPRQSRLALATRGAFVVASSAAHLLPAAAGAAVLRPLRGRTAAARFFYRRLVRHLQRLGPAPVKFGQIMGTRRDLLPPLLCDELGRLHDRVRPMSGRQVRRALREAYGPDLSRHFTEVETTARASGSIAGVYRAVRPDGREVALKLQRPGIRRRMALDLALIHGAAALAEKLPPGRGVPLAELTGFVCAAVLGQLDFAGERTNLAELRRNFAESDNVWIPATLPELCRPNCLAMEFIPDLVARPVAEIDPARRPRLAARTVSAVYQMLFLDGFVHCDLHPGNVYFKGPRVVVLDAGFSIRLDPTVRRQFADFFLGLALGRGRQCGEVVVDSAVRVAPDADVDGFIGRVAELVKRNTGVPAKEFQLTRFGTELFTLQRDFGLYAASEFVFPLLSLLVIEGTVRDLDPDIDFQAAARPMLLRAAAETAHLAPQRRAG	MRFKKISCLLLSPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNNKKYETYYGLQSVQDKKSVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTSGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKEWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANINPQKYPKDTQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	118.28	gnl|BL_ORD_ID|2441|hsp_num:0	2358			753	933	
BGC0001060.1|Dynemicin_27 # 34207 # 34839 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.684	BGC0001060.1|Dynemicin_27 	34207	34839	-	Loose	450	27.7202	rmtB	34.88	3000860	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAGCACCAAGAGCGTTCTTTTCGGTCGCCCGGTCCAGACCGAGGGCGTGCCGAACGTCTACGCCGGCGCCCCGGTCGTCCCGTGGACCCCGCCGGAGCCCGGCATCGACAACCTGGGCATCAACTCGATCGACACCTTCGCGGTGCCGGGCGTGGGCGAGTACACGGTCGCCTTCGACGGCTGGGTGCGGGTGGTCCGGTCGCCGTCCACCTCGGGCGAGTGGGCCGACGCCGAGGTCTACACCAACCTCATCGAGATGAAGATGGTCGGTGAGTGCGAGGAGCTCGGCAAGATCACCGTCACGCTCAACCCGGACTGCCTCTCGGCCGGCCAGATCCGCACCCCGTTCGACCCGTACGCGGGTGAGGGGCCGTCGGCCAAGGCCTGCCGGATGGCGGTCGGCGCGATCTTCGACATGCCGAAGCTCGGGCTGAAGCTGATGAACCGCGAGCCGATCATCCTGACCATCGACGACGTGCGCAGCATCCCGCCGGCGGGCGCCCCGGGCAAGGGCCAGATCTACCGGATGATGCCGCTGCTCGACGTCAACGACCCGGACGGCCAGCCGGTCGCGTACCTGACCAGCCTCCGGTTCAACATGGGCGGCTACCTGAAGCCCGACCAGATGTGA	MSTKSVLFGRPVQTEGVPNVYAGAPVVPWTPPEPGIDNLGINSIDTFAVPGVGEYTVAFDGWVRVVRSPSTSGEWADAEVYTNLIEMKMVGECEELGKITVTLNPDCLSAGQIRTPFDPYAGEGPSAKACRMAVGAIFDMPKLGLKLMNREPIILTIDDVRSIPPAGAPGKGQIYRMMPLLDVNDPDGQPVAYLTSLRFNMGGYLKPDQM	MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTPESLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALYERGIASVWGCDIHQGLGDVITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLLEREQAGSAMALLQSLNTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPAEFEIEDKKTIGTELIYLIKKNG	83.67	gnl|BL_ORD_ID|832|hsp_num:0	904			456	582	dibekacin; amikacin; gentamicin C; sisomicin; netilmicin; kanamycin A; tobramycin; isepamicin; G418; arbekacin; gentamicin B; gentamicin
BGC0001060.1|Dynemicin_28 # 34861 # 36186 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5bp;gc_cont=0.695	BGC0001060.1|Dynemicin_28 	34861	36186	-	Loose	450	26.9498	aadA16	33.93	3002616	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGCAATCGATCTCTGCAACAAGTCGCCGGGTGCTCTCGCGGAGGGCGCCCAGGGTGCGTGGGAGGAGGCGGTCCCGGCCGACGCGGCACCGGTCAACCTGGACGCCCTCACCGCGGACCAGCGCGACGCGCTCAACTTCTCCTACCGGACCACGCTGCCGGCGATGGACCCGCGCTTCGTCGCCGGTGACCCGGCGGCCTGGGCGAGCGACTTCGGGTACGCGCTGAACAAGGTCGCGGTCCGGCTGGACAACCGCACCAACCAGGAACTGCGCGACGCCGCGCTGAACCACCCCGACGCGGCCATGCGCGAGCAGGCCCTGTTCGAGTACGCCGACCGCGACCTGCCGGACGCGATCGAGCTGCTCGGCCAGGCCGTGCTGCACGACCCCAACCGCGAGGTCCGCTGGGACGCGCTGTGGGCCATCGAGAAGCTGGGCGGCGCCCACGCGGTCGCCAGCCTCAGCAAGTTCGCCAAGGACGCGGACCCGGAGATCGCCGAGTGGTCGCACCTGTTCCGCAGCGAGCTGCAGACGGGTGACCCGGCGTTCGACGGCCGGGCCGGCAAGTTCACCCCGGGCCGCACCTTCGACGAGACCATCTACCTGCTGATCCACTGCGACCTGTACGTGCGGCTGGACGACTCCAACCAGCACTGGGGCAAGATCTCGCTGGCCCCGCAGGGCCTGGCCCGGATCTATGGCCAGGCGCACGCCTGCCCGAACGTGGCGACCCGCGAGCGGCAGCTGGTGATCGCCAAGACCATCGACGGGCTGCACGCCGACGGCTCGCCGCACTGCGACAACTACCTGTTCCGCGGGTTCACCGACCGCACCCGCCGGGACCGGGGGAACTTCTTCTTCGAGTCGCTGGTGCCCCGGACGTTCTTCAAGTCCGGTCACGCCGACGACCCGAGCGAGGGCACCCGCCAGGCCAACATCGGCTTCGCCCGGTACGGCACCTGGCACCTCGACCCGAAGTTCCAGATCCACGACGAGGCGGCCATCCGCTACGTCCGTGGTCGCTTCCAGGGCTGGGGCTACATCAACCTGGCCCGGATCGCCGGCCGCTCCATGGAGGAGATCCTCCAGCCGGGCAACGGCGTGCTCTCCACGCTGCACGACCCGGAGATCGGCCACATGACCAACGCGTTCATCCTCGGCACCTTCAAGGGGAAGCTGAACGACTGGGACGGCGACGGGGTCATCGACATGAACTCGCGCGACGTCTACTCGACCGTCGACGGCGAGATCGACATGAACCAGGACGGCGTGGCGGACCAGCCCGGCCTGACCTGCTGCGACCACACCACCCTGCTGCCGTAA	MAIDLCNKSPGALAEGAQGAWEEAVPADAAPVNLDALTADQRDALNFSYRTTLPAMDPRFVAGDPAAWASDFGYALNKVAVRLDNRTNQELRDAALNHPDAAMREQALFEYADRDLPDAIELLGQAVLHDPNREVRWDALWAIEKLGGAHAVASLSKFAKDADPEIAEWSHLFRSELQTGDPAFDGRAGKFTPGRTFDETIYLLIHCDLYVRLDDSNQHWGKISLAPQGLARIYGQAHACPNVATRERQLVIAKTIDGLHADGSPHCDNYLFRGFTDRTRRDRGNFFFESLVPRTFFKSGHADDPSEGTRQANIGFARYGTWHLDPKFQIHDEAAIRYVRGRFQGWGYINLARIAGRSMEEILQPGNGVLSTLHDPEIGHMTNAFILGTFKGKLNDWDGDGVIDMNSRDVYSTVDGEIDMNQDGVADQPGLTCCDHTTLLP	MSNAVPAEISVQLSQALNVIERHLGSTLLAVHLYGSALDGGLKPCSDIDLLVTVTAQLDETVRQALFVDFLEVSASPGQSEALRALEVTIVVYGDVAPWRYLARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNSVPESDLFKALADTLKLWNSQPDWAGDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEAQQAYLGQGMDCLASRADQLTAFIYFVKHEAASLLGSTPMMSNSSFKPTPLRGAA	156.94	gnl|BL_ORD_ID|1615|hsp_num:0	1762			282	423	spectinomycin; streptomycin
BGC0001060.1|Dynemicin_29 # 36333 # 37826 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.809	BGC0001060.1|Dynemicin_29 	36333	37826	+	Loose	400	27.7202	Erm(38)	32.43	3000601	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCACCTGAGCCCCTCTCGCGCCCCTCCCGGATCGCCCTGCGCGCCCTGCGGCCCGCGCCGGCGCCCGTCCGGCCCACCCCCCGCGCGACCCGCTGGCGGGTGACCGGCCCGGCCGACCACCCCCTCGTCCGGCACCTGCGCCGGCAGCCCTATCCGGCCGCCGGACCCGAGGCCGACGTGCTGGTCCTCGGTGGACGGTGGCCGGCCGGCGGCGCCGGGGTGCTGCTCGACGCGTACCAGCGGGCCGCCGGGCGGCAGCTCACGCTGGTCCACGACGGAGCCGGCGGCGGCAGCCTGCTGCGCGGGCTCGGCGCCGGGGACGGCCGGCCGGTCGGCACCGTCGCGCTGGGCGACCCCACCCCGGCGGCGTTGCGCCGCGCCGCCGGCCTGCTCGCCGCGCCGTCCGCCGCCGACGAGCTCACCGTGGCCGCCGACGGCACCGTGCACACCCTCGGCTGGCGGGCCGCCCCGCTGCCCGGCCGGGCGCCACGCTTCGCCGGGGCCACCGTCCTGGTCACCGGCGGCCTGGGCGGGCTCGGCAGCCGCCTCGCCGTCGCCCTGGCCGCCGCCGGCGCCGTCCCGGTCCTGCTCGACGTGCGTACGCCTGACGACGCCCCGCCCGACGTCCGCCGGATGCTCACCCTGCTGCGGCGGCGCTGCCCCCGGGCCCGGCTGCTCACCCTCGACCTCACCGACCCGGCGGCCGCCCGCGCGGCCCTGGCCGGGCTGCGGCCCACCGCGATCGTGCACTGCGCCGGCCGGATCGCCGGCGGCACCGGGGTACGCCTCGGCCCCGCCGAGGTCGACGCCCTGGTCGCCGCGAAGGTCGCCACCCTGGAGACGGTGCTCGCCACGGTCCGCGCGAAGCGGCTGCGGGCGGTGCTCACCTTCGGCTCGCTCACCGCGCACGGCGCGCACCCGGGGCTCGCCGGCTACGCCCTCGCGAACGAACTGCTGCACCGGGCCACCGCCCGGTACGCCGCCACGCACCCCGGGGTCCGCTGCTGCACCGCCGAGTGGTCACTCTGGTCCGGCGCCGGGATGGCCCGGCAGGTGGCCCGGGTCGCCGCCCGGCACCTCGGCATGGTGCCGGTGCCGGTGGCCACCGGTGTCGCCGCGGCCACCCGGCTGCTCGCCGCGCTTGTCGACGCCCCGCCCGACGAGGACCTGCCCGACTCGCTGCTCGTCTGCAGCGAGCGCCCCGGCACGCAGGGCGCCTGGTCGGGGCGGCCGGAGGGCGTACCCGGAGTGGACGCCGCCCTGGTCGTGCCGGCCGGCGGCGACCTCGACATGGCGATGCGCGCGGTGGCCGAGGCGGCGGCCGGCGGCGCCGCGTTGATCCCGGACGGGACGGCCGGTCCGGGCGCGCCGCTGCTGGTCCGGGCCACGGTCACCGGTGACGGGGTGGACTGCGTGGTCCGCTCCGGCGCCGACCCCGACGGGCCGGCACTGCGCAGCTCCCGCTACCGGCTGCTGCCCGCCGGCACCTGA	MSPEPLSRPSRIALRALRPAPAPVRPTPRATRWRVTGPADHPLVRHLRRQPYPAAGPEADVLVLGGRWPAGGAGVLLDAYQRAAGRQLTLVHDGAGGGSLLRGLGAGDGRPVGTVALGDPTPAALRRAAGLLAAPSAADELTVAADGTVHTLGWRAAPLPGRAPRFAGATVLVTGGLGGLGSRLAVALAAAGAVPVLLDVRTPDDAPPDVRRMLTLLRRRCPRARLLTLDLTDPAAARAALAGLRPTAIVHCAGRIAGGTGVRLGPAEVDALVAAKVATLETVLATVRAKRLRAVLTFGSLTAHGAHPGLAGYALANELLHRATARYAATHPGVRCCTAEWSLWSGAGMARQVARVAARHLGMVPVPVATGVAAATRLLAALVDAPPDEDLPDSLLVCSERPGTQGAWSGRPEGVPGVDAALVVPAGGDLDMAMRAVAEAAAGGAALIPDGTAGPGAPLLVRATVTGDGVDCVVRSGADPDGPALRSSRYRLLPAGT	MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAVEVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRRLLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDAGLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPNSLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVGQRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASFDSSASTTLVSRKARVNGPTPPGLGDT	128.76	gnl|BL_ORD_ID|1004|hsp_num:0	1097			375	582	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001060.1|Dynemicin_30 # 37865 # 38716 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.735	BGC0001060.1|Dynemicin_30 	37865	38716	+	Loose	850	26.9498	opmE	26.98	3003700	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGACGGATACCTGAAACTGCCCGACGACTGGGTGCGCGTGATGGTCAGCGTGCCGGCCCCCGTGGACGAGGTGTGGGAGGCGGTCACCGACCCGCGGCGGGTCGCCCAGTGGTTCGGCCACCTGTCCGCTCCCATGACGACCGGGGCGAGCACCCGTGTCGACTTCGGTGACGGCGACTTCTTCGACATCGAGGTCGACCACGTCGAGCCGCGCGACCGCCTGCTGTTCCGGTGGAGCTTCCTCGGCGTCGGCCCGGAGTGCCAGGTCGGCTGGACGCTGACCGGCGGGGCGGAGGCCACCACGCTGACCGTGGACGACAGCTGCCCGGGCCGCCCCGGGTCGGAGGTGGCCCAGCTCAAGGCCGGGTGGCTGGACTTCGTCGGCCGGCTGGCCCGCTACCTGGAAACCGGCAAACCCTCCCGGTACGACTGGCGGCAGGAGATCGACGGCAGCGTGGTGCTGCCGAACGGCTCCTGGCACCCGCTGCGCGAGGAGACGGTGGTCGACTGGCTCCCCATCGCCACCAACGGCGCCGGCCCCGGCTGGTTCTTCGTGGTCGACGAGGAGGGCCCGCGCCGGTTCACCCTGCGCGACTGGCAGCTCGACCGCGAGCGGGCGCTCACCTTCGCGGTCGAGATCCCCGGGGCGCGCACGGTCACCGCCTGCCAGGTCCGGACGGAGCCGGGCGAGCGCGGCCGTACGCTCTCCGTCTCCCACCAGGGCTGGCACCGGCTGGGCCTCAGCGACCTCCAGGAACGGACGCTGCGGCACCGGTTCGCCGCCACCTGGACGGCCGCGCTGTCGCTGGCCGAGGAGTGCGCCCGCACCCGGCAGGAGCTGCCGTGA	MPDGYLKLPDDWVRVMVSVPAPVDEVWEAVTDPRRVAQWFGHLSAPMTTGASTRVDFGDGDFFDIEVDHVEPRDRLLFRWSFLGVGPECQVGWTLTGGAEATTLTVDDSCPGRPGSEVAQLKAGWLDFVGRLARYLETGKPSRYDWRQEIDGSVVLPNGSWHPLREETVVDWLPIATNGAGPGWFFVVDEEGPRRFTLRDWQLDRERALTFAVEIPGARTVTACQVRTEPGERGRTLSVSHQGWHRLGLSDLQERTLRHRFAATWTAALSLAEECARTRQELP	MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS	57.64	gnl|BL_ORD_ID|2019|hsp_num:0	2213			1257	1446	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
BGC0001060.1|Dynemicin_31 # 38722 # 39573 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=14bp;gc_cont=0.778	BGC0001060.1|Dynemicin_31 	38722	39573	+	Loose	230	52.7582	ramA	30.3	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGGCCCACGACCGCGCCGCCGTCCGGGGCGACCGCACCGAGCCGGCGCACCGGCGCGGCCGGTCGACAGTCCTCCAGCAGCACCGGGATGCGGTCTCCCGGGTCGTCCGGGCCATGCGGGACCGGCTCGACGAGCCGTGGACCCTGTCCCGGCTGGCCCAGGTGGCGTATCTCAGCCCGTTCCACTTCAGCCGGGTGTTCCGGCTGGTCACCGGCACCCCGCCGGGGCGGTTCCTGTCCGCGCTGCGGATGGCCGAGGCGCGCCGGCTGGTGGTCTCCAGCCGGATGAACGTCACCGACATCTGCACCACGGTCGGCTACAGCAGCCTGGGCACCTTCACCACCCAGTTCACCGAGCAGGTCGGGGTCGGGCCGGGCCGGCTGCGGCGGCTGGACGCCGCGCACGGCGACCGGCCGCTGGAGCACGTGGTCGCCGCCGGGACCGGGCCGGCGGAGGAGGACGAGCCGCCCGGGGGCGTGGTCACGGGCACCGTGCACGCCCCGGCCGGGGACGCCCGGCTGGTGCTGCTCGGGCTCTTCCCCACCCCGCTGGCCCAGGGGCTCCCCGTCGCCTGCACCAGCGTCACGGGCGACGGCCCGTTCGCCGTCACCGGCGCGCCCGAGGGCACCTGGCACCTGCTGGCCTGCGCCCACCCCGAGGCGGTCACCGTCGGCGAGGTGCTGGCCGGCGCCCGCGATCCGGACGTGTGGGTCGGGGTGGCCGACGCGCCGGTGGTGGTCCGTGCGGGCCGCACCACCGGTCCACTGGCCGTGCGGCTGGCCCCGGCCCGCCCCATCGACCCGCCGATCCTCACCGGCCTGCCGGTGCTCCCCCTCGCCGCCCGCCCGTGA	MAHDRAAVRGDRTEPAHRRGRSTVLQQHRDAVSRVVRAMRDRLDEPWTLSRLAQVAYLSPFHFSRVFRLVTGTPPGRFLSALRMAEARRLVVSSRMNVTDICTTVGYSSLGTFTTQFTEQVGVGPGRLRRLDAAHGDRPLEHVVAAGTGPAEEDEPPGGVVTGTVHAPAGDARLVLLGLFPTPLAQGLPVACTSVTGDGPFAVTGAPEGTWHLLACAHPEAVTVGEVLAGARDPDVWVGVADAPVVVRAGRTTGPLAVRLAPARPIDPPILTGLPVLPLAARP	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	228.23	gnl|BL_ORD_ID|1537|hsp_num:0	1665			54	351	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0001060.1|Dynemicin_32 # 39620 # 40876 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.741	BGC0001060.1|Dynemicin_32 	39620	40876	-	Loose	200	28.1054	vanT gene in vanC cluster	27.12	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTCGCTGCGGATGTTCCTGCGGGTGCTGGCCATCGTCGCCGTGGCGTCCGGTGAGGCGCTGCGGACCCTTCCGGCGTCCCTCGTACTGCGGGTGACCCGGGGGCCGGAGGCGGCGGCCGACCGCCGCTACCGGGGGATGGTGCGGGCGCTGCAACGGCTGGGCCCGACCTTCGTGAAGTTCGGCCAGATCGCCGGCACCCGCCGGGACGCCCTCCCGCCCGCGCTCTGCGCCCGGCTCGGCACCCTCTTCGACGAGGTGCCGCCGATGTCCGCCGCGGCGGCCGGCGAGGCGCTGCGCCGCGCCCGGGCGGAACAGCCCCGGCTGGTGCTGCGCTCGGTGGACCCCGAGCCGCTGGCCAGCGGCAGCATCGCCTCGGTCTACCGGGCCGTGCTGGACGACGGCACCGTGGTGGCGCTGAAGCTCAAGCGGCCCGGCATCGACGACCGGATGCGGGCGGACCTGCGGCTCGTCGAGCTGATGGCGCGGCTGGCCGCACGGGCGCCGAAGATGCGGGGCATGCCCATCGCCGACCTGGTCGGCTATCTCAGCGCGGCGATCCTCGGCCAGCTCGACTTCCACCGGGAGGCGGCGAACAGCGAACGGCTCCGCGGCGAGCTGGCCGAGCTGCCGGAGGTCAGGGTGCCACTGCTGCACCGGGACCGGTCGGCGTCGAACTGCCTGGTCTTCGAGTACCTGCCGGATCTGGACGGGCGGACGGTCGAGCGGCTCGACCCGCGGGTCCGGGCGCACCTCGCCGAGGTGGTGCTGGCCGCCGTGCACCGGCTCTTCTTCGGTGCCGGCTTCGTCCACTGCGACCTGCACCCGGGCAACCTCTACCTGACCCGGGACGAGCGGGTGGTGGTCCTCGATGCCGGCTACTGCGTCCAGCTGCCCGACGGCGTACGGGCGGCGATCGGTGAGTTCTTCGCCCGGCTGGGAGCGGGGGACGGCCGGCGGTGCGGCGAGATCGTGCTGGCCAGCGCGGTGAACGCCGGCGCCGGCCTGGACCGGGAGGGCTTCGTCCGGGACGTGGCGGAGCTGGTGGCCCGGACCGCCGGCCCGGACAACGAGTTCGACATGTCGGTCTTCGGCAACGGCGTGTACGACCTCCAGCAGCGGTACGGCATCTACGCCGCCTCCGACTTCGCCTTCCCGCTCATGTCCCTGCTGGTGGTCGAGGGCACGGTGCGCGGGATCAGCCCCGACGTCGACTTCCAGCGGGTCGGTGGACCGGCGCCCACCCCGCACGCGTGA	MSLRMFLRVLAIVAVASGEALRTLPASLVLRVTRGPEAAADRRYRGMVRALQRLGPTFVKFGQIAGTRRDALPPALCARLGTLFDEVPPMSAAAAGEALRRARAEQPRLVLRSVDPEPLASGSIASVYRAVLDDGTVVALKLKRPGIDDRMRADLRLVELMARLAARAPKMRGMPIADLVGYLSAAILGQLDFHREAANSERLRGELAELPEVRVPLLHRDRSASNCLVFEYLPDLDGRTVERLDPRVRAHLAEVVLAAVHRLFFGAGFVHCDLHPGNLYLTRDERVVVLDAGYCVQLPDGVRAAIGEFFARLGAGDGRRCGEIVLASAVNAGAGLDREGFVRDVAELVARTAGPDNEFDMSVFGNGVYDLQQRYGIYAASDFAFPLMSLLVVEGTVRGISPDVDFQRVGGPAPTPHA	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	59.89	gnl|BL_ORD_ID|4675|hsp_num:0	734			1203	1380	vancomycin
BGC0001060.1|Dynemicin_33 # 40887 # 42023 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGCGG;rbs_spacer=4bp;gc_cont=0.775	BGC0001060.1|Dynemicin_33 	40887	42023	-	Loose	750	94.7449	tet(51)	26.87	3004586	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACGACTCGACGGGCGCTCGTCGTCGGCGGCGGGCCGGCCGGGCTGGCGACCGCGCTGGCCCTGCGGGACGCGGGCTGGGACGCGCTGGTCCTCGAACGCAGCGCGGACGAGGGGCCCTCCGGCGTCGCCCTCACCCTCTGGCCGAACGCCCTGTCGGCACTCGCCGCCGTCGGTGCCGACAAGCCGGTACGGGCGGCCGGCTGCCCGGCCGACGGCAACCAGATCCGCGCCGCCGACGGGCGGATCCTCGACGACGTGCCGGGGCGGTTGATGGCGGAGCGCTTCGGCGGCCGGGGCCTGGCGCTGCTCCGTGCCGACCTGGTCGAGGCGCTGCGCGCCCAACTCTCCCCGGGGATGCTGCGCACCGGCGCCCGCTGCGTGGGCTGGACGGAGTACGGCGGCCGGGTACGCGTCACCCTCGCCGACGGCGGCACCGAGGTGGGCGACCTCCTCGTCGGCGCGGACGGACTGCGCTCGACGATCCGCCGCCAGTTGCTCGGCGGCGGCGCGGACCCGCTGCGCTACGCGGGTTACCCGGTCTGGCGCGGCATCGCCCGGTACGACCTCGGCGCCGCGCCGGGCCTGCTCACCATGGGCCGGGCCGCCCAGTTCGGGCTGTTCCCGCTGCCCGAGGGGCGGGCGTACTGGTTCGCCACCATGCCGCTGCGCCGGGGCTGGGGTGAGCAGTTGCCCCGCCGGGTCTGGGCGGCCCGGTTCGACGGCTGGCACGCGCCCATCCCGCAGGTGCTGGCCGCCACCCCGGACGAGGACGTCCTGGTCACCGACATCTACGACCGCGCGCCCGTGCCCCGGTGGAGCGCCGGGCGGGTGGTCCTGGTCGGCGACGCCGCGCACCCCAGCACCCCGAACCTGGGCCAGGGCACCTGCCAGGCGCTGGAGGACGCCGTCGTGCTGGGCCGCTGCCTGCGCGACGACGACGTGGCCGAGGCCCTGCCCCGGTACGAGGCGGCGCGCCGCCGTCGGGCGGACGGCCTCACCCGCCAGGCCCGGATGCTCGGCCGGGTCGGGCAGTGGAGCAACCCGGTGGCCTGCTGGATCCGGGAGCAGATGATCCGCCGCGCCCCGGCCGGTCCGCGGCTGCGGCAGATGGCGGAGATGTTCGCCTTCGAGTGA	MTTRRALVVGGGPAGLATALALRDAGWDALVLERSADEGPSGVALTLWPNALSALAAVGADKPVRAAGCPADGNQIRAADGRILDDVPGRLMAERFGGRGLALLRADLVEALRAQLSPGMLRTGARCVGWTEYGGRVRVTLADGGTEVGDLLVGADGLRSTIRRQLLGGGADPLRYAGYPVWRGIARYDLGAAPGLLTMGRAAQFGLFPLPEGRAYWFATMPLRRGWGEQLPRRVWAARFDGWHAPIPQVLAATPDEDVLVTDIYDRAPVPRWSAGRVVLVGDAAHPSTPNLGQGTCQALEDAVVLGRCLRDDDVAEALPRYEAARRRRADGLTRQARMLGRVGQWSNPVACWIREQMIRRAPAGPRLRQMAEMFAFE	MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE	97.67	gnl|BL_ORD_ID|2723|hsp_num:0	3288			12	993	tetracycline; oxytetracycline
BGC0001060.1|Dynemicin_34 # 42238 # 42666 # 1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5bp;gc_cont=0.681	BGC0001060.1|Dynemicin_34 	42238	42666	+	Loose	700	27.7202	adeS	27.4	3000549	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTCAGCACCTGACAACAAGGCGGTCGTGCGGCAGCTCATCGACGCCTGGAACAACGGCGACATCAACGCCCTGATGACCTTCTGGTCACCGACGATGGTGCACCACGGCCGGGCCGGCACGATCAGCGCCGAGGACACCGCGGCCGAGATGCGGCGCTTCCTCGACGCCTTCCCCGACCTGCGCATGGAGCTGCACAGCATCGTCTCCGAGGGCGAACTCGTGGCCACCCGGATGACCGTGCACGCCACGCACACCGGCGCGTACATGGGCATCCCGCCGACCGACCGCCCGGTGAGCTGCGCCCTCATGGGGCAGTTGCGGATCGTCGACGGCGTCGTGGTCGACCACTGGGGGGTGGCCGACGCGCTGGGCATCCTCGTGCAGATCGGAATGCTGCCGTCCGAACTGTCCACCGCCTTTTCCTGA	MSAPDNKAVVRQLIDAWNNGDINALMTFWSPTMVHHGRAGTISAEDTAAEMRRFLDAFPDLRMELHSIVSEGELVATRMTVHATHTGAYMGIPPTDRPVSCALMGQLRIVDGVVVDHWGVADALGILVQIGMLPSELSTAFS	MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEMG	39.34	gnl|BL_ORD_ID|166|hsp_num:0	183			636	849	tigecycline; tetracycline
BGC0001060.1|Dynemicin_35 # 42703 # 43206 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.698	BGC0001060.1|Dynemicin_35 	42703	43206	+	Loose	1650	26.9498	Listeria monocytogenes mprF	45.45	3003770	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGACCGGACACCACCCGGATCTGGCGCAGCGCAAACGCGAGTTCGAGGAGACCGTGCGGAATTTCCGCAAGGCGGTGCTGTTCGACTACGACCTCACGGCCGTGCAGCACGTCCTCGCGCCGGGCTTCGTCGACCATTTCGCCCCGCCGTGGGACCCGCCGAGCCGCGACGGCGTGGCGCACCGGTTCGACCACGCGAACCAGGTGCTCACCACCCGCAAGGTCGAGGTGCTCGTGTCGGTGTGCGAGGGCGACATCCTGGCCCAGGCCATCCTGCTGCACTTCGAGCACACCGGGCCGTTCATGGGCATCCCGGCGACCGGCCGCCGGTTCGAGATCGGCGGCTCCAACACGTTCCGGTTCGAGAACGGCAGGATCGCCGAGCACTGGGGCGTCTTCGACGTCGCGAAGATCCCCGACCTGCTGGCCGGCGAGCCGGGTGCGGCCGGCGGCTGGTCGTCCATGTGGGACCGCGAGGAGATCGGCACCGCCGGCAAGGGCTGA	MTGHHPDLAQRKREFEETVRNFRKAVLFDYDLTAVQHVLAPGFVDHFAPPWDPPSRDGVAHRFDHANQVLTTRKVEVLVSVCEGDILAQAILLHFEHTGPFMGIPATGRRFEIGGSNTFRFENGRIAEHWGVFDVAKIPDLLAGEPGAAGGWSSMWDREEIGTAGKG	MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRASFYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYFPILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPDYLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVSHTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEIIEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASMMPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE	19.31	gnl|BL_ORD_ID|2056|hsp_num:0	2279			444	510	defensin
BGC0001060.1|Dynemicin_36 # 43334 # 44230 # -1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.755	BGC0001060.1|Dynemicin_36 	43334	44230	-	Loose	2030	25.409	ceoB	29.23	3003010	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGGGACGATCCTGGTCACCGGCGCCACCGGCCGGGTCGGGTCGGAGCTGGTCCGGCTGCTCGCCGGAGCCGGCGTCCGGCCCCGGGCCCTGGTCCGCGACGTCGAGCGGGCCCGGCAGAAGCTCGGGGACGCCGCGGACCTGGTCGCCGGTGACCTGAACCGGCCGGCGGACCTGGACGCCGCGCTGGCCGGGGTGGAGCGGCTGTTCGTGCTCACGGCGACCAGCCGGGGGCAGCTCACCCAGGAGCGCAACGCGATCGACGCGGCGGTACGCGCCGGCGTGCGGCACGTGGTGAAGCTGTCGGTGCTGGACGCCGGACGCGAGTCGCCGCTGCGGCACGGCGTCTGGCAGGGCGACGCGAACGCGCTGCTGGTCAACTCCGCGGTCGACCACACCGTGCTGCAACTGGCGTTCTTCATGCAGAACCTGTTCGGGATGGTGGCCGGGGGCGCGATCCGCAGCTCGGCCGGTGACGGCCGGGTGGCGATGGTCGACGCGCGGGACGTGGCGGCCGCCGCGACGGCGGTGCTCACCGACTGCCCCGACTGGGCGCGCAACGAGACACTGGTGCTGTCCGGCCCGGAGGCGCTCTCCTTCGACGACACGGCGAAGGTGCTGGCCGAGGCCACCGGTGTCCCGGTGCGCCACCTTCCGGTGCCGCGTGAGCAGGTGGCCGCCATGCTGCGGCAGTTCGGCGCCGAGGAGTGGTACGCCGAGGACGTGGCGGTGTTCAACGACCTGATCGCCGCCGGCCGGGTCCAGGCGGTCACCGACACCGTGCGGCGGCTGACCGGCGCCGAGCCCCGGTCGCTGGGCGACTTCGCCCGGGAGTTCGCGGCCGTCTTCCAGCGGGCGGCCGCACCGCCGCCGGGCGGGTGGCGGGCTGGCTGA	MSGTILVTGATGRVGSELVRLLAGAGVRPRALVRDVERARQKLGDAADLVAGDLNRPADLDAALAGVERLFVLTATSRGQLTQERNAIDAAVRAGVRHVVKLSVLDAGRESPLRHGVWQGDANALLVNSAVDHTVLQLAFFMQNLFGMVAGGAIRSSAGDGRVAMVDARDVAAAATAVLTDCPDWARNETLVLSGPEALSFDDTAKVLAEATGVPVRHLPVPREQVAAMLRQFGAEEWYAEDVAVFNDLIAAGRVQAVTDTVRRLTGAEPRSLGDFAREFAAVFQRAAAPPPGGWRAG	MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI	29.02	gnl|BL_ORD_ID|1148|hsp_num:0	1252			1401	1596	
BGC0001060.1|Dynemicin_37 # 44227 # 45660 # -1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.734	BGC0001060.1|Dynemicin_37 	44227	45660	-	Loose	500	28.4906	mphF	30.88	3003071	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCCGTCGATGTTCACAGCAGCGACCTGGCCCGCTTCCACCGGCAGCGCCTGACCTGGCAGCCGACCGAGGGCGGGGCGGGTACGGAGACCAGCCGCGTCACCGTCCCGCTCGACTACCGCGACCCCGCCGGGCGCACCATCGAGATCGCCGTGGCCCGCCGGCCCGCCGGCGATCCCGGGCAGCGGATCGGGGTGCTGATGATCGCGCCCGACGACCCGGGCAACCGGGGCATCCCGCTGATCGGGCAGCTCGTCGGGGCGCTTCCGGCCGAGGTGCTGGACCGGTTCGACCTGGTCGCCTTCGACCACCGGTTCAGCGGCGACAGCCACCCCATCGAGGTGGACTGGACGCCCGAGGAGCGGCTCTGGGTCTTCCACCGGCCCCAGAGCATCACCGAGGAGATCCGGTTCCAGTCCAAGGTGGCCGCCAAGGTCGCCGACGTCGCGCTGGACCTGCTGCCGCACGCCAGCACCCGCAACGTGGCCCGGGACATGGACGTCGTCCGGGCCGCGCTCGGCGAGGAGAGGATCTCCTACCTCGGCTGGTCGTACGGGACCTACCTGGGCGCGGTCTACACCCAGCTGTTCGGCGAGCGGGCCGACCGGGTGGTGCTGGACAGCGTGCTCAGCCCGGACTGGCCCTGGCGCGGGCTCTTCCTCAACGTCGCGGCCAGCACCGAGGCGGCGGTGAACCGCTGGTGCGGCTGGGCCGCGGCGCGCGACGGCGAGCTGCGCCTGGGCGACAGCGCGGCGGCGGTCCGGTCCCGCTACGACGAGCTGCTGGAGCGGGCCGGCCGGGAGCCGCTGGCCGTGCCCGGGCTGCCCATGCCGCTGGACCGGTTCGCGCTGGAGTTCTTCACCGTGGTGATGCTGACCGCGGACCGCACGTACCCGCTGCTCGGCGCGGTGCTGAGGGCCGCGGTGCACGGCGACCCGGTGCCCGGCCCGGCGGTCGGCGAGCTGATGGGACTTGTCAACCAGCGCCAGGACAGCACCCCGGCCGGGCAGCTCGCCATCCTCTGCGGCGAGTCGAGCTGGCCGCGCGACCTCGACCGGTACGAGGCCGAGATGGCGAGTGTGGGCGCGGAGCTGCCGTTCATCGGGCGCACCCTGGCCTCGGTGAAGGCCGGCGCGTTCTGGCCGACCTCGCCCGTGGAGCCGCTGACCGAGATCGGGCCGGGGAACAGCGCCCGGTCGATCCTGCTCGTGCAGTCCGAGGCGGACATCTTCACCCGGGCGGTCGGGGCGTGGCGGCTGCGCGAGCTGCTGCCGGAGAACAGCCGGCTCGTGCTCGCCGCCGACACGGCGTGCCACAAGCTCTTCCCGTTCGGGGGGCACCCGGTGGTCAACGAGCTGACCACCCGGTACCTGCTGACCGGCGAGCTGCCGGAGAAGGACGTGACCGTCGAGAACCACCAGGAGTCGGCATGA	MSVDVHSSDLARFHRQRLTWQPTEGGAGTETSRVTVPLDYRDPAGRTIEIAVARRPAGDPGQRIGVLMIAPDDPGNRGIPLIGQLVGALPAEVLDRFDLVAFDHRFSGDSHPIEVDWTPEERLWVFHRPQSITEEIRFQSKVAAKVADVALDLLPHASTRNVARDMDVVRAALGEERISYLGWSYGTYLGAVYTQLFGERADRVVLDSVLSPDWPWRGLFLNVAASTEAAVNRWCGWAAARDGELRLGDSAAAVRSRYDELLERAGREPLAVPGLPMPLDRFALEFFTVVMLTADRTYPLLGAVLRAAVHGDPVPGPAVGELMGLVNQRQDSTPAGQLAILCGESSWPRDLDRYEAEMASVGAELPFIGRTLASVKAGAFWPTSPVEPLTEIGPGNSARSILLVQSEADIFTRAVGAWRLRELLPENSRLVLAADTACHKLFPFGGHPVVNELTTRYLLTGELPEKDVTVENHQESA	MLHDTDRILKLAREAGLELAPGSLRLNEMGLDFQVAFGRDGDAVEWVLRMPRRTDVACAAVKEAKILDYFRSRLPVAVPDWKVFSDDLIAYPSLPGNPGLTFDASTYETTWHFDQNSPVYVETLGAALAQLHGLDTDDAISAGLSNLSIDAVRENWTRDLETVEKSFEVPAARLALWRAWLADLSFWPTHAASVHGDLYVGHVMVKSDGTVCGIIDWSEAHIGDPGIDLAGHLKVFGEASLRDLLGHYEAAGGQTWPRIVEHCKMLQSAEGIRYAMFALKTGSAEHLEGAQGLLSAPGI	159.53	gnl|BL_ORD_ID|444|hsp_num:0	473			372	567	erythromycin; roxithromycin; clarithromycin; tylosin; azithromycin
